Exelixis Inc. (EXEL) NASDAQ
$23.38 0.51 (2.23%)
Market Cap: $6.74B
As of 04/23/24 12:10 PM EDT. Market open.
Exelixis Inc. (EXEL)
NASDAQ
$23.38
0.51 (2.23%)
Market Cap: $6.74B
As of 04/23/24 12:10 PM EDT. Market open.
Add to Portfolio
exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. our first commercial product, cometriq® (cabozantinib), ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$945,080
CEO Compensation (Total)
$7.98M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
1,493
CEO Compensation (Base)
$945,080
CEO Compensation (Total)
$7.98M
URL
Address
.
PRICE CHART FOR EXELIXIS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$23.19
Previous Close
$22.87
Days Range
$22.61 - $23.06
52 week range
$18.08 - $24.34
Volume
575,428
Avg. Volume (30 days)
2,017,435
Market Cap
$6.74B
Dividend Yield
-
P/E
32.45
Shares Outstanding
294,799,955
Open
$23.19
Previous Close
$22.87
Days Range
$22.61 - $23.06
52 week range
$18.08 - $24.34
Volume
575,428
Avg. Volume (30 days)
2,017,435
Market Cap
$6.74B
Dividend Yield
-
P/E
32.45
Shares Outstanding
294,799,955
FINANCIAL STATEMENTS FOR EXELIXIS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR EXELIXIS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Garber Alan M | Director | Mar 21, 2024 | Option Exercise | $19.57 | 23,491 | 459,719 | 54,908 | Mar 25, 2024, 07:31 PM |
| Garber Alan M | Director | Mar 21, 2024 | Sale | $24.01 | 19,205 | 461,112 | 35,703 | Mar 25, 2024, 07:31 PM |
| Haley Patrick J. | EVP, Commercial | Feb 23, 2024 | Sale | $21.45 | 47,020 | 1,008,579 | 384,866 | Feb 27, 2024, 06:58 PM |
| JOHNSON DAVID EDWARD | Director | Feb 21, 2024 | Buy | $20.70 | 190,000 | 3,932,734 | 1,100,730 | Feb 22, 2024, 05:08 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 15, 2024 | Option Exercise | $20.39 | 10,630 | 216,746 | 479,031 | Feb 16, 2024, 07:21 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 11, 2024 | Option Exercise | $22.86 | 63,717 | 1,456,571 | 796,657 | Jan 16, 2024, 08:50 PM |
| Senner Christopher J. | EVP and CFO | Jan 11, 2024 | Option Exercise | $22.86 | 21,862 | 499,765 | 669,869 | Jan 16, 2024, 08:50 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Jan 11, 2024 | Option Exercise | $22.86 | 13,061 | 298,574 | 591,702 | Jan 16, 2024, 08:50 PM |
| Haley Patrick J. | EVP, Commercial | Jan 11, 2024 | Option Exercise | $22.86 | 13,613 | 311,193 | 368,536 | Jan 16, 2024, 08:50 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Jan 11, 2024 | Option Exercise | $22.86 | 11,606 | 265,313 | 489,661 | Jan 16, 2024, 08:50 PM |
| Haley Patrick J. | EVP, Commercial | Dec 14, 2023 | Option Exercise | $16.29 | 50,000 | 814,500 | 357,687 | Dec 14, 2023, 07:56 PM |
| Haley Patrick J. | EVP, Commercial | Dec 12, 2023 | Sale | $22.50 | 14,149 | 318,353 | 307,687 | Dec 14, 2023, 07:56 PM |
| Haley Patrick J. | EVP, Commercial | Dec 14, 2023 | Sale | $23.35 | 50,000 | 1,167,500 | 307,687 | Dec 14, 2023, 07:56 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Dec 13, 2023 | Sale | $23.01 | 25,000 | 575,250 | 533,345 | Dec 14, 2023, 07:55 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Dec 04, 2023 | Sale | $22.06 | 25,000 | 551,500 | 558,345 | Dec 04, 2023, 06:22 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Nov 30, 2023 | Sale | $22.01 | 25,000 | 550,250 | 583,345 | Dec 04, 2023, 06:22 PM |
| JOHNSON DAVID EDWARD | Director | Nov 27, 2023 | Buy | $21.61 | 120,409 | 2,602,039 | 910,730 | Nov 29, 2023, 04:30 PM |
| JOHNSON DAVID EDWARD | Director | Nov 27, 2023 | Sale | $21.61 | 120,409 | 2,602,039 | 790,321 | Nov 29, 2023, 04:30 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 06, 2023 | Option Exercise | $22.27 | 46,608 | 1,037,960 | 726,893 | Sep 08, 2023, 09:28 PM |
| Senner Christopher J. | EVP and CFO | Sep 06, 2023 | Option Exercise | $22.27 | 17,147 | 381,864 | 611,545 | Sep 08, 2023, 09:26 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Sep 06, 2023 | Option Exercise | $22.27 | 12,560 | 279,711 | 438,043 | Sep 08, 2023, 09:25 PM |
| Haley Patrick J. | EVP, Commercial | Sep 06, 2023 | Option Exercise | $22.27 | 14,354 | 319,664 | 321,836 | Sep 08, 2023, 09:24 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Sep 06, 2023 | Option Exercise | $22.27 | 14,354 | 319,664 | 608,345 | Sep 08, 2023, 09:22 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Aug 30, 2023 | Sale | $22.47 | 4,600 | 103,362 | 399,943 | Sep 01, 2023, 08:15 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 28, 2023 | Option Exercise | $22.18 | 303,779 | 6,737,818 | 641,717 | Aug 30, 2023, 09:48 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 28, 2023 | Option Exercise | $15.31 | 360,000 | 5,511,600 | 945,496 | Aug 30, 2023, 09:48 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 15, 2023 | Option Exercise | $21.51 | 23,304 | 501,269 | 585,496 | Aug 17, 2023, 08:20 PM |
| Senner Christopher J. | EVP and CFO | Aug 15, 2023 | Option Exercise | $21.51 | 8,074 | 173,672 | 563,557 | Aug 17, 2023, 08:19 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 15, 2023 | Option Exercise | $21.51 | 7,177 | 154,377 | 564,799 | Aug 17, 2023, 08:17 PM |
| Haley Patrick J. | EVP, Commercial | Aug 15, 2023 | Option Exercise | $21.51 | 7,177 | 154,377 | 278,290 | Aug 17, 2023, 08:16 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Aug 15, 2023 | Option Exercise | $21.51 | 6,280 | 135,083 | 404,543 | Aug 17, 2023, 08:14 PM |
| Senner Christopher J. | EVP and CFO | Aug 04, 2023 | Option Exercise | $14.74 | 60,000 | 884,400 | 631,631 | Aug 07, 2023, 09:20 PM |
| Senner Christopher J. | EVP and CFO | Aug 03, 2023 | Option Exercise | $14.74 | 60,000 | 884,400 | 631,631 | Aug 07, 2023, 09:20 PM |
| Senner Christopher J. | EVP and CFO | Aug 04, 2023 | Sale | $20.68 | 60,000 | 1,240,800 | 571,631 | Aug 07, 2023, 09:20 PM |
| Senner Christopher J. | EVP and CFO | Aug 03, 2023 | Sale | $20.51 | 60,000 | 1,230,600 | 571,631 | Aug 07, 2023, 09:20 PM |
| Haley Patrick J. | EVP, Commercial | Aug 03, 2023 | Sale | $20.67 | 30,553 | 631,531 | 285,467 | Aug 07, 2023, 08:24 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 01, 2023 | Option Exercise | $14.74 | 55,710 | 821,165 | 627,686 | Aug 03, 2023, 08:02 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 01, 2023 | Sale | $19.63 | 55,710 | 1,093,587 | 571,976 | Aug 03, 2023, 08:02 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | May 15, 2023 | Option Exercise | $19.18 | 11,967 | 229,527 | 579,003 | May 17, 2023, 08:20 PM |
| Senner Christopher J. | EVP and CFO | May 15, 2023 | Option Exercise | $19.18 | 18,446 | 353,794 | 581,633 | May 17, 2023, 08:16 PM |
| MORRISSEY MICHAEL | President and CEO | May 15, 2023 | Option Exercise | $19.18 | 33,518 | 642,875 | 608,800 | May 17, 2023, 08:14 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | May 15, 2023 | Option Exercise | $19.18 | 10,488 | 201,160 | 416,938 | May 17, 2023, 08:12 PM |
| Haley Patrick J. | EVP, Commercial | May 15, 2023 | Option Exercise | $19.18 | 18,065 | 346,487 | 331,059 | May 17, 2023, 08:09 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Apr 05, 2023 | Option Exercise | $14.74 | 13,930 | 205,328 | 621,365 | Apr 05, 2023, 08:57 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Apr 05, 2023 | Sale | $20.01 | 38,930 | 778,989 | 582,435 | Apr 05, 2023, 08:57 PM |
| WYSZOMIERSKI JACK L | Director | Mar 10, 2023 | Option Exercise | $6.30 | 40,000 | 252,000 | 332,767 | Mar 14, 2023, 08:22 PM |
| WYSZOMIERSKI JACK L | Director | Mar 10, 2023 | Sale | $16.61 | 15,300 | 254,133 | 317,467 | Mar 14, 2023, 08:22 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Mar 01, 2023 | Option Exercise | $14.74 | 27,860 | 410,656 | 605,576 | Mar 03, 2023, 07:59 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Mar 01, 2023 | Sale | $17.13 | 77,860 | 1,333,742 | 527,716 | Mar 03, 2023, 07:59 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28, 2023 | Option Exercise | $14.74 | 82,490 | 1,215,903 | 433,962 | Mar 01, 2023, 07:56 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27, 2023 | Option Exercise | $14.74 | 10 | 147 | 351,482 | Mar 01, 2023, 07:56 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27, 2023 | Sale | $17.50 | 10 | 175 | 351,472 | Mar 01, 2023, 07:56 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28, 2023 | Sale | $17.50 | 82,490 | 1,443,575 | 351,472 | Mar 01, 2023, 07:56 PM |
| Garber Alan M | Director | Feb 21, 2023 | Option Exercise | $6.30 | 40,000 | 252,000 | 71,417 | Feb 23, 2023, 09:08 PM |
| Garber Alan M | Director | Feb 21, 2023 | Sale | $17.49 | 40,000 | 699,600 | 31,417 | Feb 23, 2023, 09:08 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 15, 2023 | Option Exercise | $18.08 | 11,522 | 208,318 | 329,133 | Feb 17, 2023, 09:46 PM |
| Haley Patrick J. | EVP, Commercial | Feb 15, 2023 | Option Exercise | $18.08 | 1,556 | 28,132 | 252,858 | Feb 17, 2023, 09:44 PM |
| Senner Christopher J. | EVP and CFO | Feb 15, 2023 | Option Exercise | $18.08 | 5,278 | 95,426 | 504,663 | Feb 17, 2023, 09:42 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Feb 15, 2023 | Option Exercise | $18.08 | 1,929 | 34,876 | 577,716 | Feb 17, 2023, 09:41 PM |
| Aftab Dana | CSO/EVP Disc & Trans Research | Feb 15, 2023 | Option Exercise | $18.08 | 1,529 | 27,644 | 351,472 | Feb 17, 2023, 09:39 PM |
| Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | Feb 15, 2023 | Option Exercise | $18.08 | 17,299 | 312,766 | 225,088 | Feb 17, 2023, 09:38 PM |
| FELDBAUM CARL B | Director | Feb 09, 2023 | Option Exercise | $6.30 | 40,000 | 252,000 | 58,701 | Feb 10, 2023, 07:56 PM |
| FELDBAUM CARL B | Director | Feb 09, 2023 | Sale | $17.78 | 40,000 | 711,200 | 18,701 | Feb 10, 2023, 07:56 PM |
| Haley Patrick J. | EVP, Commercial | Feb 06, 2023 | Option Exercise | $4.20 | 25,000 | 105,000 | 279,414 | Feb 08, 2023, 08:17 PM |
| Haley Patrick J. | EVP, Commercial | Feb 06, 2023 | Sale | $17.37 | 25,000 | 434,250 | 254,414 | Feb 08, 2023, 08:17 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 24, 2023 | Option Exercise | $17.36 | 62,006 | 1,076,424 | 378,649 | Jan 26, 2023, 08:59 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 24, 2023 | Option Exercise | $4.20 | 100,000 | 420,000 | 440,655 | Jan 26, 2023, 08:59 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2022 | Option Exercise | $4.20 | 20,000 | 84,000 | 430,958 | Dec 16, 2022, 08:09 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2022 | Sale | $15.88 | 20,000 | 317,600 | 410,958 | Dec 16, 2022, 08:09 PM |
| POSTE GEORGE | Director | Nov 29, 2022 | Option Exercise | $6.30 | 40,000 | 252,000 | 233,189 | Dec 01, 2022, 08:11 PM |
| POSTE GEORGE | Director | Nov 29, 2022 | Sale | $16.68 | 40,000 | 667,200 | 193,189 | Dec 01, 2022, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Nov 15, 2022 | Option Exercise | $16.71 | 7,177 | 119,928 | 254,414 | Nov 17, 2022, 08:48 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Nov 15, 2022 | Option Exercise | $16.71 | 7,177 | 119,928 | 579,645 | Nov 17, 2022, 08:46 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | May 16, 2022 | Sale | $20.07 | 18,000 | 361,260 | 586,822 | Nov 17, 2022, 08:46 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | May 17, 2021 | Sale | $25.39 | 18,000 | 457,020 | 604,822 | Nov 17, 2022, 08:46 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2022 | Option Exercise | $16.71 | 7,177 | 119,928 | 410,958 | Nov 17, 2022, 08:42 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2022 | Option Exercise | $16.71 | 23,304 | 389,410 | 446,665 | Nov 17, 2022, 08:40 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2022 | Option Exercise | $16.71 | 8,074 | 134,917 | 509,941 | Nov 17, 2022, 08:38 PM |
| Haley Patrick J. | EVP, Commercial | Sep 12, 2022 | Option Exercise | $6.21 | 40,000 | 248,400 | 301,591 | Sep 14, 2022, 07:57 PM |
| Haley Patrick J. | EVP, Commercial | Sep 12, 2022 | Sale | $17.94 | 40,000 | 717,600 | 261,591 | Sep 14, 2022, 07:57 PM |
| Senner Christopher J. | EVP and CFO | Aug 11, 2022 | Option Exercise | $19.23 | 152,867 | 2,939,632 | 518,015 | Aug 12, 2022, 08:23 PM |
| Senner Christopher J. | EVP and CFO | Aug 11, 2022 | Option Exercise | $6.21 | 225,000 | 1,397,250 | 670,882 | Aug 12, 2022, 08:23 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 03, 2022 | Option Exercise | $21.49 | 23,304 | 500,803 | 469,969 | Aug 05, 2022, 09:50 PM |
| Senner Christopher J. | EVP and CFO | Aug 03, 2022 | Option Exercise | $21.49 | 8,074 | 173,510 | 445,882 | Aug 05, 2022, 09:48 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Aug 03, 2022 | Option Exercise | $21.49 | 7,177 | 154,234 | 418,135 | Aug 05, 2022, 09:45 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 03, 2022 | Option Exercise | $21.49 | 7,177 | 154,234 | 622,804 | Aug 05, 2022, 09:44 PM |
| Haley Patrick J. | EVP, Commercial | Aug 03, 2022 | Option Exercise | $21.49 | 7,177 | 154,234 | 261,591 | Aug 05, 2022, 09:43 PM |
| Haley Patrick J. | EVP, Commercial | May 27, 2022 | Sale | $18.21 | 18,812 | 342,567 | 239,818 | Jun 01, 2022, 08:28 PM |
| Haley Patrick J. | EVP, Commercial | May 15, 2022 | Option Exercise | $20.08 | 11,723 | 235,398 | 266,014 | May 17, 2022, 08:29 PM |
| Senner Christopher J. | EVP and CFO | May 15, 2022 | Option Exercise | $20.08 | 8,444 | 169,556 | 421,389 | May 17, 2022, 08:23 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | May 15, 2022 | Option Exercise | $20.08 | 6,123 | 122,950 | 396,362 | May 17, 2022, 08:22 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | May 15, 2022 | Option Exercise | $20.08 | 5,349 | 107,408 | 601,031 | May 17, 2022, 08:19 PM |
| WILLSEY LANCE | Director | May 12, 2022 | Option Exercise | $3.13 | 40,000 | 125,200 | 464,415 | May 13, 2022, 08:10 PM |
| WILLSEY LANCE | Director | May 12, 2022 | Sale | $19.65 | 40,000 | 786,000 | 424,415 | May 13, 2022, 08:10 PM |
| WYSZOMIERSKI JACK L | Director | Apr 04, 2022 | Option Exercise | $3.13 | 40,000 | 125,200 | 279,888 | Apr 06, 2022, 08:08 PM |
| WYSZOMIERSKI JACK L | Director | Apr 04, 2022 | Sale | $23.00 | 6,696 | 154,008 | 273,192 | Apr 06, 2022, 08:08 PM |
| Haley Patrick J. | EVP, Commercial | Apr 01, 2022 | Option Exercise | $6.21 | 10,000 | 62,100 | 279,191 | Apr 04, 2022, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Mar 31, 2022 | Option Exercise | $6.21 | 10,000 | 62,100 | 279,191 | Apr 04, 2022, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Apr 01, 2022 | Sale | $23.00 | 10,000 | 230,000 | 269,191 | Apr 04, 2022, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Mar 31, 2022 | Sale | $22.43 | 10,000 | 224,300 | 269,191 | Apr 04, 2022, 08:11 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Mar 29, 2022 | Sale | $22.00 | 13,283 | 292,226 | 605,236 | Mar 30, 2022, 08:17 PM |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Mar 28, 2022 | Sale | $22.00 | 4,717 | 103,774 | 618,519 | Mar 30, 2022, 08:17 PM |
| Garber Alan M | Director | Mar 01, 2022 | Option Exercise | $3.13 | 40,000 | 125,200 | 52,718 | Mar 03, 2022, 08:07 PM |
| Garber Alan M | Director | Mar 01, 2022 | Sale | $21.00 | 21,301 | 447,321 | 31,417 | Mar 03, 2022, 08:07 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Feb 24, 2022 | Sale | $20.00 | 18,000 | 360,000 | 555,361 | Feb 28, 2022, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Feb 25, 2022 | Sale | $19.53 | 31,238 | 610,078 | 198,476 | Feb 28, 2022, 08:09 PM |
| PAPADOPOULOS STELIOS | Director | Feb 22, 2022 | Sale | $19.56 | 84,515 | 1,653,113 | 1,220,036 | Feb 24, 2022, 08:22 PM |
| FELDBAUM CARL B | Director | Feb 22, 2022 | Option Exercise | $3.13 | 20,000 | 62,600 | 28,521 | Feb 24, 2022, 08:20 PM |
| FELDBAUM CARL B | Director | Feb 22, 2022 | Sale | $19.49 | 20,000 | 389,800 | 8,521 | Feb 24, 2022, 08:20 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 15, 2022 | Option Exercise | $18.59 | 20,177 | 375,090 | 360,646 | Feb 17, 2022, 08:09 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Feb 15, 2022 | Option Exercise | $18.59 | 12,226 | 227,281 | 584,570 | Feb 17, 2022, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 15, 2022 | Option Exercise | $18.59 | 65,147 | 1,211,083 | 187,900 | Feb 17, 2022, 08:06 PM |
| Senner Christopher J. | EVP and CFO | Feb 15, 2022 | Option Exercise | $18.59 | 18,327 | 340,699 | 369,474 | Feb 17, 2022, 08:04 PM |
| Haley Patrick J. | EVP, Commercial | Feb 15, 2022 | Option Exercise | $18.59 | 15,527 | 288,647 | 244,443 | Feb 17, 2022, 07:59 PM |
| Haley Patrick J. | EVP, Commercial | Feb 03, 2022 | Option Exercise | $1.90 | 60,000 | 114,000 | 305,241 | Feb 04, 2022, 09:52 PM |
| Haley Patrick J. | EVP, Commercial | Feb 03, 2022 | Sale | $17.91 | 60,000 | 1,074,600 | 245,241 | Feb 04, 2022, 09:52 PM |
| Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | Jan 04, 2022 | Option Exercise | $19.18 | 7,613 | 146,017 | 242,387 | Jan 06, 2022, 08:02 PM |
| MORRISSEY MICHAEL | President and CEO | Dec 15, 2021 | Option Exercise | $17.00 | 12,236 | 208,012 | 205,006 | Dec 17, 2021, 08:41 PM |
| Haley Patrick J. | EVP, Commercial | Dec 15, 2021 | Option Exercise | $17.00 | 1,556 | 26,452 | 245,241 | Dec 17, 2021, 08:38 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2021 | Option Exercise | $17.00 | 4,646 | 78,982 | 363,172 | Dec 17, 2021, 08:35 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2021 | Option Exercise | $6.21 | 47,500 | 294,975 | 410,672 | Dec 17, 2021, 08:35 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2021 | Sale | $17.44 | 47,500 | 828,400 | 363,172 | Dec 17, 2021, 08:35 PM |
| Senner Christopher J. | EVP and CFO | Dec 15, 2021 | Option Exercise | $17.00 | 5,131 | 87,227 | 372,175 | Dec 17, 2021, 08:32 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Dec 15, 2021 | Option Exercise | $17.00 | 2,621 | 44,557 | 585,587 | Dec 17, 2021, 08:26 PM |
| Haley Patrick J. | EVP, Commercial | Nov 24, 2021 | Sale | $17.25 | 17,236 | 297,321 | 237,802 | Nov 26, 2021, 07:39 PM |
| FELDBAUM CARL B | Director | Nov 19, 2021 | Option Exercise | $3.13 | 20,000 | 62,600 | 28,521 | Nov 23, 2021, 08:11 PM |
| FELDBAUM CARL B | Director | Nov 19, 2021 | Sale | $17.62 | 20,000 | 352,400 | 8,521 | Nov 23, 2021, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Nov 15, 2021 | Option Exercise | $18.10 | 49,490 | 895,769 | 300,205 | Nov 17, 2021, 08:40 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2021 | Option Exercise | $18.10 | 57,713 | 1,044,605 | 407,301 | Nov 17, 2021, 08:39 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2021 | Option Exercise | $18.10 | 54,611 | 988,459 | 626,268 | Nov 17, 2021, 08:37 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2021 | Option Exercise | $18.10 | 193,780 | 3,507,418 | 550,538 | Nov 17, 2021, 08:33 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2021 | Option Exercise | $18.10 | 62,163 | 1,125,150 | 404,422 | Nov 17, 2021, 08:02 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2021 | Option Exercise | $6.21 | 47,500 | 294,975 | 458,740 | Nov 17, 2021, 08:02 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2021 | Sale | $18.09 | 47,500 | 859,275 | 411,240 | Nov 17, 2021, 08:02 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 01, 2021 | Sale | $22.03 | 5,117 | 112,728 | 632,825 | Nov 03, 2021, 08:12 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 22, 2021 | Option Exercise | $21.33 | 24,747 | 527,854 | 561,068 | Oct 22, 2021, 08:19 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Oct 15, 2021 | Option Exercise | $6.21 | 47,500 | 294,975 | 458,740 | Oct 15, 2021, 08:15 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Oct 15, 2021 | Sale | $21.92 | 47,500 | 1,041,200 | 411,240 | Oct 15, 2021, 08:15 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Oct 15, 2021 | Sale | $22.02 | 12,883 | 283,684 | 637,942 | Oct 15, 2021, 08:14 PM |
| Senner Christopher J. | EVP and CFO | Sep 30, 2021 | Option Exercise | $20.63 | 8,573 | 176,861 | 415,528 | Oct 04, 2021, 08:13 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 30, 2021 | Option Exercise | $20.63 | 7,593 | 156,644 | 650,825 | Oct 04, 2021, 08:12 PM |
| Haley Patrick J. | EVP, Commercial | Sep 30, 2021 | Option Exercise | $20.63 | 5,416 | 111,732 | 304,528 | Oct 04, 2021, 08:08 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sep 30, 2021 | Option Exercise | $20.63 | 7,177 | 148,062 | 411,240 | Oct 04, 2021, 08:02 PM |
| Senner Christopher J. | EVP and CFO | Sep 21, 2021 | Option Exercise | $20.33 | 55,057 | 1,119,309 | 391,534 | Sep 23, 2021, 08:16 PM |
| Senner Christopher J. | EVP and CFO | Sep 21, 2021 | Option Exercise | $3.66 | 90,000 | 329,400 | 446,591 | Sep 23, 2021, 08:16 PM |
| Haley Patrick J. | EVP, Commercial | Sep 16, 2021 | Option Exercise | $1.70 | 25,000 | 42,500 | 305,994 | Sep 17, 2021, 07:58 PM |
| Haley Patrick J. | EVP, Commercial | Sep 16, 2021 | Sale | $20.36 | 25,000 | 509,000 | 280,994 | Sep 17, 2021, 07:58 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sep 15, 2021 | Option Exercise | $6.21 | 47,500 | 294,975 | 436,967 | Sep 17, 2021, 07:56 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sep 15, 2021 | Sale | $20.46 | 47,500 | 971,850 | 389,467 | Sep 17, 2021, 07:56 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Aug 16, 2021 | Option Exercise | $1.90 | 55,000 | 104,500 | 444,467 | Aug 18, 2021, 07:56 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Aug 16, 2021 | Sale | $18.44 | 55,000 | 1,014,200 | 389,467 | Aug 18, 2021, 07:56 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jul 26, 2021 | Option Exercise | $4.20 | 40,000 | 168,000 | 689,078 | Jul 28, 2021, 08:06 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jul 21, 2021 | Option Exercise | $4.20 | 35,000 | 147,000 | 649,078 | Jul 23, 2021, 07:47 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jul 15, 2021 | Option Exercise | $1.90 | 60,000 | 114,000 | 449,467 | Jul 16, 2021, 07:58 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jul 15, 2021 | Sale | $17.47 | 60,000 | 1,048,200 | 389,467 | Jul 16, 2021, 07:58 PM |
| COHEN CHARLES | Director | Jul 06, 2021 | Option Exercise | $4.72 | 80,000 | 377,200 | 261,375 | Jul 08, 2021, 07:45 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2021 | Option Exercise | $1.90 | 60,000 | 114,000 | 449,467 | Jun 22, 2021, 08:03 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2021 | Sale | $22.18 | 60,000 | 1,330,800 | 389,467 | Jun 22, 2021, 08:03 PM |
| Freire Maria C | Director | May 11, 2021 | Sale | $25.01 | 8,275 | 206,958 | 31,827 | May 17, 2021, 08:15 PM |
| POSTE GEORGE | Director | May 14, 2021 | Sale | $24.97 | 40,802 | 1,018,826 | 157,190 | May 17, 2021, 08:11 PM |
| MORRISSEY MICHAEL | President and CEO | May 12, 2021 | Option Exercise | $25.16 | 30,278 | 761,794 | 511,535 | May 14, 2021, 08:51 PM |
| MORRISSEY MICHAEL | President and CEO | May 12, 2021 | Option Exercise | $4.20 | 50,000 | 210,000 | 541,813 | May 14, 2021, 08:51 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | May 13, 2021 | Option Exercise | $1.90 | 100,000 | 190,000 | 714,078 | May 14, 2021, 08:35 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | May 13, 2021 | Sale | $25.38 | 100,000 | 2,538,000 | 614,078 | May 14, 2021, 08:35 PM |
| PAPADOPOULOS STELIOS | Director | May 11, 2021 | Option Exercise | $4.27 | 120,000 | 512,400 | 1,293,600 | May 13, 2021, 08:32 PM |
| PAPADOPOULOS STELIOS | Director | May 11, 2021 | Sale | $24.98 | 20,770 | 518,794 | 1,288,127 | May 13, 2021, 08:32 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 26, 2021 | Option Exercise | $1.70 | 50,000 | 85,000 | 663,482 | Apr 28, 2021, 08:10 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 26, 2021 | Sale | $25.00 | 50,000 | 1,250,000 | 613,482 | Apr 28, 2021, 08:10 PM |
| Haley Patrick J. | EVP, Commercial | Apr 26, 2021 | Sale | $25.03 | 7,665 | 191,855 | 297,392 | Apr 28, 2021, 08:08 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Apr 26, 2021 | Sale | $25.03 | 18,000 | 450,540 | 628,248 | Apr 28, 2021, 08:06 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Apr 01, 2021 | Option Exercise | $1.70 | 60,000 | 102,000 | 449,467 | Apr 02, 2021, 07:51 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Apr 01, 2021 | Sale | $22.96 | 60,000 | 1,377,600 | 389,467 | Apr 02, 2021, 07:51 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 01, 2021 | Option Exercise | $1.70 | 50,000 | 85,000 | 663,482 | Apr 02, 2021, 07:41 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 01, 2021 | Sale | $23.00 | 50,000 | 1,150,000 | 613,482 | Apr 02, 2021, 07:41 PM |
| WYSZOMIERSKI JACK L | Director | Mar 29, 2021 | Option Exercise | $3.38 | 40,000 | 135,200 | 237,809 | Mar 31, 2021, 09:02 PM |
| WYSZOMIERSKI JACK L | Director | Mar 29, 2021 | Sale | $22.64 | 6,220 | 140,821 | 231,589 | Mar 31, 2021, 09:02 PM |
| Garber Alan M | Director | Mar 15, 2021 | Option Exercise | $3.38 | 40,000 | 135,200 | 52,718 | Mar 17, 2021, 08:11 PM |
| Garber Alan M | Director | Mar 15, 2021 | Sale | $23.60 | 40,000 | 944,000 | 12,718 | Mar 17, 2021, 08:11 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2021 | Option Exercise | $1.70 | 65,000 | 110,500 | 405,072 | Mar 03, 2021, 07:49 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2021 | Sale | $22.11 | 65,000 | 1,437,150 | 340,072 | Mar 03, 2021, 07:49 PM |
| COHEN CHARLES | Director | Feb 24, 2021 | Option Exercise | $3.38 | 40,000 | 135,200 | 221,375 | Feb 26, 2021, 08:10 PM |
| COHEN CHARLES | Director | Feb 24, 2021 | Sale | $22.69 | 40,000 | 907,600 | 181,375 | Feb 26, 2021, 08:10 PM |
| POSTE GEORGE | Director | Feb 22, 2021 | Option Exercise | $3.38 | 40,000 | 135,200 | 197,992 | Feb 24, 2021, 08:18 PM |
| MARCHESI VINCENT T | Director | Feb 22, 2021 | Sale | $22.29 | 24,097 | 537,122 | 66,115 | Feb 24, 2021, 08:15 PM |
| WILLSEY LANCE | Director | Feb 23, 2021 | Option Exercise | $3.38 | 40,000 | 135,200 | 464,415 | Feb 24, 2021, 08:11 PM |
| WILLSEY LANCE | Director | Feb 16, 2021 | Sale | $21.90 | 50,000 | 1,095,000 | 424,415 | Feb 24, 2021, 08:11 PM |
| WILLSEY LANCE | Director | Feb 23, 2021 | Sale | $21.93 | 40,000 | 877,136 | 425,215 | Feb 24, 2021, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 18, 2021 | Option Exercise | $1.70 | 50,000 | 85,000 | 590,597 | Feb 19, 2021, 07:57 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 17, 2021 | Option Exercise | $1.70 | 50,000 | 85,000 | 590,597 | Feb 19, 2021, 07:57 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 18, 2021 | Sale | $22.35 | 50,000 | 1,117,500 | 540,597 | Feb 19, 2021, 07:57 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 17, 2021 | Sale | $22.50 | 50,000 | 1,125,000 | 540,597 | Feb 19, 2021, 07:57 PM |
| Haley Patrick J. | EVP, Commercial | Feb 15, 2021 | Option Exercise | $21.91 | 1,400 | 30,674 | 245,487 | Feb 17, 2021, 08:15 PM |
| Haley Patrick J. | EVP, Commercial | Feb 12, 2021 | Sale | $21.57 | 45,000 | 970,650 | 246,887 | Feb 17, 2021, 08:15 PM |
| Senner Christopher J. | EVP and CFO | Feb 15, 2021 | Option Exercise | $21.91 | 4,105 | 89,941 | 292,441 | Feb 17, 2021, 08:13 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Feb 15, 2021 | Option Exercise | $21.91 | 1,685 | 36,918 | 589,113 | Feb 17, 2021, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 15, 2021 | Option Exercise | $21.91 | 2,858 | 62,619 | 540,597 | Feb 17, 2021, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 15, 2021 | Option Exercise | $21.91 | 9,789 | 214,477 | 559,187 | Feb 17, 2021, 08:07 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 15, 2021 | Option Exercise | $21.91 | 3,718 | 81,461 | 340,072 | Feb 17, 2021, 08:05 PM |
| FELDBAUM CARL B | Director | Feb 16, 2021 | Option Exercise | $3.38 | 20,000 | 67,600 | 28,521 | Feb 17, 2021, 08:03 PM |
| FELDBAUM CARL B | Director | Feb 16, 2021 | Sale | $21.96 | 20,000 | 439,200 | 8,521 | Feb 17, 2021, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 03, 2021 | Option Exercise | $22.56 | 65,190 | 1,470,686 | 568,976 | Feb 05, 2021, 09:53 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 03, 2021 | Option Exercise | $22.56 | 19,997 | 451,132 | 343,790 | Feb 05, 2021, 09:18 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Feb 03, 2021 | Option Exercise | $22.56 | 15,365 | 346,634 | 590,798 | Feb 05, 2021, 09:16 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 03, 2021 | Option Exercise | $22.56 | 14,982 | 337,994 | 543,455 | Feb 05, 2021, 09:16 PM |
| Haley Patrick J. | EVP, Commercial | Feb 03, 2021 | Option Exercise | $22.56 | 11,267 | 254,184 | 291,887 | Feb 05, 2021, 09:15 PM |
| Senner Christopher J. | EVP and CFO | Feb 03, 2021 | Option Exercise | $22.56 | 18,206 | 410,727 | 296,546 | Feb 05, 2021, 09:14 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2021 | Option Exercise | $1.70 | 65,000 | 110,500 | 348,124 | Feb 03, 2021, 07:57 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2021 | Sale | $22.08 | 65,000 | 1,435,200 | 283,124 | Feb 03, 2021, 07:57 PM |
| Senner Christopher J. | EVP and CFO | Jan 12, 2021 | Option Exercise | $3.66 | 30,000 | 109,800 | 275,596 | Jan 14, 2021, 08:22 PM |
| Senner Christopher J. | EVP and CFO | Jan 12, 2021 | Sale | $25.00 | 30,000 | 750,000 | 245,596 | Jan 14, 2021, 08:22 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jan 04, 2021 | Option Exercise | $1.70 | 65,000 | 110,500 | 348,124 | Jan 06, 2021, 08:40 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jan 04, 2021 | Sale | $20.32 | 65,000 | 1,320,800 | 283,124 | Jan 06, 2021, 08:40 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Jan 04, 2021 | Option Exercise | $5.12 | 50,000 | 256,100 | 541,754 | Jan 06, 2021, 08:22 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 18, 2020 | Option Exercise | $1.70 | 65,000 | 110,500 | 348,124 | Dec 22, 2020, 07:58 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 18, 2020 | Sale | $20.01 | 65,000 | 1,300,650 | 283,124 | Dec 22, 2020, 07:58 PM |
| WILLSEY LANCE | Director | Dec 04, 2020 | Option Exercise | $5.82 | 106,142 | 617,746 | 474,415 | Dec 04, 2020, 07:56 PM |
| MARCHESI VINCENT T | Director | Nov 24, 2020 | Option Exercise | $5.82 | 40,004 | 232,823 | 130,216 | Nov 25, 2020, 07:46 PM |
| MARCHESI VINCENT T | Director | Nov 24, 2020 | Sale | $18.50 | 40,004 | 740,074 | 90,212 | Nov 25, 2020, 07:46 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2020 | Option Exercise | $20.16 | 24,954 | 503,073 | 592,308 | Nov 17, 2020, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Nov 15, 2020 | Option Exercise | $20.16 | 10,446 | 210,591 | 248,352 | Nov 17, 2020, 08:09 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2020 | Option Exercise | $20.16 | 13,597 | 274,116 | 256,456 | Nov 17, 2020, 08:07 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2020 | Option Exercise | $20.16 | 11,311 | 228,030 | 291,956 | Nov 17, 2020, 08:06 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2020 | Option Exercise | $20.16 | 10,261 | 206,862 | 472,942 | Nov 17, 2020, 08:00 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2020 | Option Exercise | $7.27 | 30,000 | 218,100 | 494,254 | Nov 17, 2020, 08:00 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 15, 2020 | Option Exercise | $20.16 | 14,953 | 301,452 | 489,667 | Nov 17, 2020, 07:57 PM |
| WYSZOMIERSKI JACK L | Director | Nov 10, 2020 | Option Exercise | $5.82 | 62,403 | 363,185 | 231,809 | Nov 13, 2020, 08:18 PM |
| WYSZOMIERSKI JACK L | Director | Nov 10, 2020 | Sale | $20.61 | 34,000 | 700,740 | 197,809 | Nov 13, 2020, 08:18 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 22, 2020 | Option Exercise | $21.79 | 177,132 | 3,859,706 | 598,834 | Oct 26, 2020, 08:12 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Oct 22, 2020 | Option Exercise | $21.79 | 55,235 | 1,203,571 | 491,835 | Oct 26, 2020, 08:11 PM |
| Haley Patrick J. | EVP, Commercial | Oct 22, 2020 | Option Exercise | $21.79 | 44,184 | 962,769 | 249,618 | Oct 26, 2020, 08:07 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Oct 22, 2020 | Option Exercise | $21.79 | 46,742 | 1,018,508 | 474,515 | Oct 26, 2020, 08:04 PM |
| Senner Christopher J. | EVP and CFO | Oct 22, 2020 | Option Exercise | $21.79 | 46,920 | 1,022,387 | 259,193 | Oct 26, 2020, 08:00 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Oct 22, 2020 | Option Exercise | $21.79 | 53,022 | 1,155,349 | 294,435 | Oct 26, 2020, 07:57 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Oct 21, 2020 | Option Exercise | $7.27 | 39,742 | 288,924 | 382,768 | Oct 23, 2020, 08:08 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Oct 21, 2020 | Sale | $21.95 | 39,742 | 872,337 | 343,026 | Oct 23, 2020, 08:08 PM |
| Senner Christopher J. | EVP and CFO | Oct 08, 2020 | Option Exercise | $3.66 | 10,000 | 36,600 | 137,882 | Oct 09, 2020, 08:04 PM |
| Senner Christopher J. | EVP and CFO | Oct 08, 2020 | Sale | $25.00 | 10,000 | 250,000 | 127,882 | Oct 09, 2020, 08:04 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 22, 2020 | Option Exercise | $7.27 | 10,258 | 74,576 | 353,284 | Sep 24, 2020, 08:03 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 22, 2020 | Sale | $26.14 | 10,258 | 268,144 | 343,026 | Sep 24, 2020, 08:03 PM |
| Haley Patrick J. | EVP, Commercial | Sep 21, 2020 | Option Exercise | $5.82 | 4,680 | 27,238 | 120,251 | Sep 23, 2020, 08:12 PM |
| Haley Patrick J. | EVP, Commercial | Sep 21, 2020 | Sale | $26.09 | 4,680 | 122,101 | 115,571 | Sep 23, 2020, 08:12 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 16, 2020 | Option Exercise | $7.27 | 20,000 | 145,400 | 363,026 | Sep 16, 2020, 08:24 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 16, 2020 | Sale | $26.11 | 20,000 | 522,200 | 343,026 | Sep 16, 2020, 08:24 PM |
| Senner Christopher J. | EVP and CFO | Sep 15, 2020 | Option Exercise | $3.66 | 20,000 | 73,200 | 147,882 | Sep 15, 2020, 08:03 PM |
| Senner Christopher J. | EVP and CFO | Sep 15, 2020 | Sale | $25.00 | 20,000 | 500,000 | 127,882 | Sep 15, 2020, 08:03 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 08, 2020 | Option Exercise | $20.71 | 160,666 | 3,327,393 | 343,026 | Sep 10, 2020, 08:39 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 08, 2020 | Option Exercise | $5.18 | 249,692 | 1,293,315 | 503,692 | Sep 10, 2020, 08:39 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sep 02, 2020 | Option Exercise | $21.58 | 2,323 | 50,130 | 133,578 | Sep 04, 2020, 06:41 PM |
| Haley Patrick J. | EVP, Commercial | Sep 02, 2020 | Option Exercise | $21.58 | 1,116 | 24,083 | 115,571 | Sep 04, 2020, 06:40 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 02, 2020 | Option Exercise | $21.58 | 1,311 | 28,291 | 254,000 | Sep 04, 2020, 06:38 PM |
| Senner Christopher J. | EVP and CFO | Sep 02, 2020 | Option Exercise | $21.58 | 2,566 | 55,374 | 127,882 | Sep 04, 2020, 06:36 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sep 02, 2020 | Option Exercise | $21.58 | 2,517 | 54,317 | 333,191 | Sep 04, 2020, 06:32 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 02, 2020 | Option Exercise | $21.58 | 6,118 | 132,026 | 103,105 | Sep 04, 2020, 06:31 PM |
| COHEN CHARLES | Director | Sep 01, 2020 | Option Exercise | $5.82 | 115,396 | 671,605 | 181,375 | Sep 03, 2020, 08:05 PM |
| POSTE GEORGE | Director | Aug 14, 2020 | Option Exercise | $5.82 | 29,662 | 172,633 | 157,992 | Aug 14, 2020, 07:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 20, 2020 | Option Exercise | $25.60 | 64,137 | 1,641,907 | 121,848 | Jul 22, 2020, 07:06 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 20, 2020 | Option Exercise | $6.21 | 100,000 | 621,000 | 185,985 | Jul 22, 2020, 07:06 PM |
| Haley Patrick J. | EVP, Commercial | Jul 20, 2020 | Sale | $25.36 | 3,151 | 79,909 | 112,189 | Jul 22, 2020, 07:01 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 10, 2020 | Option Exercise | $24.94 | 64,441 | 1,607,159 | 121,544 | Jul 10, 2020, 08:48 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 10, 2020 | Option Exercise | $6.21 | 100,000 | 621,000 | 185,985 | Jul 10, 2020, 08:48 PM |
| MORRISSEY MICHAEL | President and CEO | Jun 19, 2020 | Option Exercise | $24.18 | 64,811 | 1,567,130 | 121,174 | Jun 19, 2020, 09:20 PM |
| MORRISSEY MICHAEL | President and CEO | Jun 19, 2020 | Option Exercise | $6.21 | 100,000 | 621,000 | 185,985 | Jun 19, 2020, 09:20 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 08, 2020 | Option Exercise | $5.51 | 26,000 | 143,260 | 152,531 | Jun 10, 2020, 08:19 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 08, 2020 | Sale | $22.56 | 26,000 | 586,560 | 126,531 | Jun 10, 2020, 08:19 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jun 04, 2020 | Option Exercise | $1.70 | 100,000 | 170,000 | 425,963 | Jun 05, 2020, 08:00 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jun 04, 2020 | Sale | $22.96 | 100,000 | 2,296,000 | 325,963 | Jun 05, 2020, 08:00 PM |
| MORRISSEY MICHAEL | President and CEO | May 29, 2020 | Option Exercise | $24.71 | 64,550 | 1,595,030 | 121,435 | May 29, 2020, 09:36 PM |
| MORRISSEY MICHAEL | President and CEO | May 29, 2020 | Option Exercise | $6.21 | 100,000 | 621,000 | 185,985 | May 29, 2020, 09:36 PM |
| MARCHESI VINCENT T | Director | May 21, 2020 | Option Exercise | $5.82 | 40,000 | 232,800 | 130,212 | May 22, 2020, 09:11 PM |
| MARCHESI VINCENT T | Director | May 21, 2020 | Sale | $24.64 | 40,000 | 985,600 | 90,212 | May 22, 2020, 09:11 PM |
| Garber Alan M | Director | May 22, 2020 | Sale | $24.42 | 36,111 | 881,831 | 12,718 | May 22, 2020, 08:53 PM |
| Haley Patrick J. | EVP, Commercial | May 20, 2020 | Sale | $24.99 | 3,151 | 78,743 | 115,340 | May 22, 2020, 08:17 PM |
| WILLSEY LANCE | Director | May 18, 2020 | Option Exercise | $4.58 | 30,000 | 137,400 | 398,273 | May 20, 2020, 08:36 PM |
| WILLSEY LANCE | Director | May 18, 2020 | Sale | $26.26 | 30,000 | 787,800 | 368,273 | May 20, 2020, 08:36 PM |
| SCANGOS GEORGE A | Director | May 18, 2020 | Sale | $25.96 | 75,000 | 1,947,000 | 714,717 | May 20, 2020, 08:35 PM |
| MORRISSEY MICHAEL | President and CEO | May 15, 2020 | Option Exercise | $25.76 | 64,065 | 1,650,314 | 121,920 | May 15, 2020, 09:29 PM |
| MORRISSEY MICHAEL | President and CEO | May 15, 2020 | Option Exercise | $6.21 | 100,000 | 621,000 | 185,985 | May 15, 2020, 09:29 PM |
| SCANGOS GEORGE A | Director | May 15, 2020 | Option Exercise | $5.10 | 51,686 | 263,613 | 789,717 | May 15, 2020, 08:31 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 13, 2020 | Option Exercise | $26.53 | 13,875 | 368,104 | 250,313 | May 15, 2020, 08:20 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 13, 2020 | Option Exercise | $1.70 | 25,000 | 42,500 | 264,188 | May 15, 2020, 08:20 PM |
| WILLSEY LANCE | Director | May 14, 2020 | Option Exercise | $5.92 | 15,000 | 88,800 | 383,273 | May 15, 2020, 08:19 PM |
| WILLSEY LANCE | Director | May 14, 2020 | Sale | $25.26 | 15,000 | 378,900 | 368,273 | May 15, 2020, 08:19 PM |
| PAPADOPOULOS STELIOS | Director | May 13, 2020 | Option Exercise | $5.82 | 120,791 | 703,004 | 1,173,359 | May 15, 2020, 08:18 PM |
| MARCHESI VINCENT T | Director | May 11, 2020 | Option Exercise | $4.58 | 30,000 | 137,400 | 112,484 | May 13, 2020, 09:16 PM |
| MARCHESI VINCENT T | Director | May 11, 2020 | Sale | $26.30 | 30,000 | 789,000 | 82,484 | May 13, 2020, 09:16 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 07, 2020 | Option Exercise | $1.90 | 30,000 | 57,000 | 269,188 | May 11, 2020, 08:36 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 11, 2020 | Option Exercise | $1.90 | 38,006 | 72,211 | 277,194 | May 11, 2020, 08:36 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 08, 2020 | Option Exercise | $1.90 | 25,000 | 47,500 | 264,188 | May 11, 2020, 08:36 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 11, 2020 | Sale | $27.09 | 38,006 | 1,029,583 | 239,188 | May 11, 2020, 08:36 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 08, 2020 | Sale | $26.04 | 25,000 | 651,000 | 239,188 | May 11, 2020, 08:36 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 07, 2020 | Sale | $25.61 | 30,000 | 768,300 | 239,188 | May 11, 2020, 08:36 PM |
| Senner Christopher J. | EVP and CFO | May 08, 2020 | Option Exercise | $3.66 | 78,583 | 287,614 | 199,286 | May 08, 2020, 09:22 PM |
| Senner Christopher J. | EVP and CFO | May 07, 2020 | Option Exercise | $3.66 | 21,417 | 78,386 | 142,120 | May 08, 2020, 09:22 PM |
| Senner Christopher J. | EVP and CFO | May 08, 2020 | Sale | $25.81 | 78,583 | 2,028,227 | 120,703 | May 08, 2020, 09:22 PM |
| Senner Christopher J. | EVP and CFO | May 07, 2020 | Sale | $25.80 | 21,417 | 552,559 | 120,703 | May 08, 2020, 09:22 PM |
| PAPADOPOULOS STELIOS | Director | May 08, 2020 | Option Exercise | $5.03 | 45,000 | 226,200 | 1,097,568 | May 08, 2020, 09:18 PM |
| PAPADOPOULOS STELIOS | Director | May 08, 2020 | Sale | $25.84 | 45,000 | 1,162,800 | 1,052,568 | May 08, 2020, 09:18 PM |
| Haley Patrick J. | EVP, Commercial | May 08, 2020 | Option Exercise | $1.76 | 21,375 | 37,620 | 139,866 | May 08, 2020, 09:16 PM |
| Haley Patrick J. | EVP, Commercial | May 08, 2020 | Sale | $25.87 | 21,375 | 552,971 | 118,491 | May 08, 2020, 09:16 PM |
| FELDBAUM CARL B | Director | May 07, 2020 | Option Exercise | $4.27 | 31,546 | 134,798 | 40,067 | May 08, 2020, 09:14 PM |
| FELDBAUM CARL B | Director | May 07, 2020 | Sale | $25.02 | 31,546 | 789,281 | 8,521 | May 08, 2020, 09:14 PM |
| POSTE GEORGE | Director | May 07, 2020 | Option Exercise | $5.82 | 30,000 | 174,600 | 142,792 | May 08, 2020, 09:13 PM |
| POSTE GEORGE | Director | May 07, 2020 | Sale | $25.61 | 30,000 | 768,300 | 112,792 | May 08, 2020, 09:13 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | May 07, 2020 | Option Exercise | $5.51 | 50,000 | 275,500 | 176,531 | May 08, 2020, 09:11 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | May 07, 2020 | Sale | $25.54 | 50,000 | 1,277,000 | 126,531 | May 08, 2020, 09:11 PM |
| MORRISSEY MICHAEL | President and CEO | May 06, 2020 | Option Exercise | $26.19 | 158,971 | 4,163,451 | 212,298 | May 08, 2020, 09:10 PM |
| MORRISSEY MICHAEL | President and CEO | May 06, 2020 | Option Exercise | $1.70 | 285,284 | 484,983 | 371,269 | May 08, 2020, 09:10 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 27, 2020 | Option Exercise | $27.37 | 158,435 | 4,336,366 | 212,550 | Apr 29, 2020, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 27, 2020 | Option Exercise | $1.70 | 285,000 | 484,500 | 370,985 | Apr 29, 2020, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 23, 2020 | Option Exercise | $26.37 | 156,360 | 4,123,213 | 179,625 | Apr 24, 2020, 08:41 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 23, 2020 | Option Exercise | $5.51 | 250,000 | 1,377,500 | 335,985 | Apr 24, 2020, 08:41 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 23, 2020 | Option Exercise | $1.70 | 100,000 | 170,000 | 425,122 | Apr 24, 2020, 08:25 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 23, 2020 | Sale | $26.00 | 100,000 | 2,600,000 | 325,122 | Apr 24, 2020, 08:25 PM |
| SCANGOS GEORGE A | Director | Apr 24, 2020 | Sale | $26.24 | 15,000 | 393,600 | 738,031 | Apr 24, 2020, 08:24 PM |
| SCANGOS GEORGE A | Director | Apr 23, 2020 | Sale | $25.99 | 100,000 | 2,598,635 | 808,731 | Apr 24, 2020, 08:24 PM |
| Haley Patrick J. | EVP, Commercial | Apr 23, 2020 | Option Exercise | $1.70 | 5,000 | 8,500 | 121,873 | Apr 24, 2020, 08:22 PM |
| Haley Patrick J. | EVP, Commercial | Apr 23, 2020 | Sale | $26.00 | 5,000 | 130,000 | 116,873 | Apr 24, 2020, 08:22 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 21, 2020 | Option Exercise | $24.56 | 139,201 | 3,418,776 | 253,863 | Apr 22, 2020, 09:53 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 20, 2020 | Option Exercise | $23.58 | 152,921 | 3,605,877 | 173,064 | Apr 22, 2020, 09:53 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 21, 2020 | Option Exercise | $5.51 | 220,000 | 1,212,200 | 393,064 | Apr 22, 2020, 09:53 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 20, 2020 | Option Exercise | $5.51 | 240,000 | 1,322,400 | 325,985 | Apr 22, 2020, 09:53 PM |
| SCANGOS GEORGE A | Director | Apr 21, 2020 | Sale | $25.04 | 5,800 | 145,232 | 857,231 | Apr 22, 2020, 08:50 PM |
| SCANGOS GEORGE A | Director | Apr 20, 2020 | Sale | $23.89 | 50,000 | 1,194,637 | 894,531 | Apr 22, 2020, 08:50 PM |
| SCANGOS GEORGE A | Director | Apr 22, 2020 | Sale | $25.05 | 4,200 | 105,210 | 853,031 | Apr 22, 2020, 08:50 PM |
| Haley Patrick J. | EVP, Commercial | Apr 20, 2020 | Option Exercise | $1.70 | 5,000 | 8,500 | 121,873 | Apr 22, 2020, 08:49 PM |
| Haley Patrick J. | EVP, Commercial | Apr 20, 2020 | Sale | $24.00 | 5,000 | 120,000 | 116,873 | Apr 22, 2020, 08:49 PM |
| SCANGOS GEORGE A | Director | Apr 15, 2020 | Sale | $18.31 | 25,000 | 457,750 | 913,031 | Apr 17, 2020, 08:11 PM |
| SCANGOS GEORGE A | Director | Apr 08, 2020 | Sale | $18.35 | 7,065 | 129,643 | 938,031 | Apr 09, 2020, 08:20 PM |
| SCANGOS GEORGE A | Director | Apr 07, 2020 | Sale | $18.25 | 16,435 | 299,939 | 945,096 | Apr 09, 2020, 08:20 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Apr 06, 2020 | Option Exercise | $5.51 | 50,000 | 275,500 | 176,531 | Apr 08, 2020, 08:12 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Apr 06, 2020 | Sale | $17.26 | 50,000 | 863,000 | 126,531 | Apr 08, 2020, 08:12 PM |
| WYSZOMIERSKI JACK L | Director | Apr 03, 2020 | Option Exercise | $5.03 | 45,000 | 226,200 | 175,526 | Apr 03, 2020, 08:38 PM |
| WYSZOMIERSKI JACK L | Director | Apr 03, 2020 | Sale | $16.57 | 13,848 | 229,461 | 161,678 | Apr 03, 2020, 08:38 PM |
| SCANGOS GEORGE A | Director | Mar 31, 2020 | Sale | $18.06 | 1,500 | 27,090 | 961,531 | Apr 02, 2020, 08:08 PM |
| Haley Patrick J. | EVP, Commercial | Mar 20, 2020 | Sale | $15.37 | 4,318 | 66,368 | 116,873 | Mar 20, 2020, 09:03 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 04, 2020 | Option Exercise | $19.89 | 32,884 | 654,063 | 103,101 | Mar 06, 2020, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 04, 2020 | Option Exercise | $5.51 | 50,000 | 275,500 | 135,985 | Mar 06, 2020, 08:07 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Mar 04, 2020 | Option Exercise | $1.70 | 100,000 | 170,000 | 425,122 | Mar 06, 2020, 08:01 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Mar 04, 2020 | Sale | $19.40 | 100,000 | 1,940,000 | 375,122 | Mar 06, 2020, 08:01 PM |
| FELDBAUM CARL B | Director | Mar 03, 2020 | Option Exercise | $5.62 | 38,000 | 213,720 | 46,521 | Mar 05, 2020, 08:00 PM |
| FELDBAUM CARL B | Director | Mar 03, 2020 | Sale | $18.84 | 38,000 | 716,013 | 9,174 | Mar 05, 2020, 08:00 PM |
| COHEN CHARLES | Director | Feb 28, 2020 | Option Exercise | $5.03 | 45,000 | 226,200 | 65,979 | Mar 02, 2020, 09:14 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 26, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Feb 28, 2020, 08:05 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 26, 2020 | Sale | $18.91 | 25,000 | 472,850 | 86,485 | Feb 28, 2020, 08:05 PM |
| SCANGOS GEORGE A | Director | Feb 18, 2020 | Sale | $20.73 | 50,000 | 1,036,500 | 963,031 | Feb 21, 2020, 08:28 PM |
| Haley Patrick J. | EVP, Commercial | Feb 19, 2020 | Sale | $22.00 | 5,000 | 110,000 | 121,191 | Feb 21, 2020, 08:17 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 19, 2020 | Sale | $21.75 | 25,000 | 543,750 | 85,985 | Feb 21, 2020, 08:03 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 19, 2020 | Option Exercise | $5.51 | 40,000 | 220,400 | 365,122 | Feb 21, 2020, 08:00 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 19, 2020 | Sale | $21.50 | 40,000 | 860,000 | 325,122 | Feb 21, 2020, 08:00 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 13, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Feb 14, 2020, 08:48 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 13, 2020 | Sale | $20.11 | 25,000 | 502,750 | 85,985 | Feb 14, 2020, 08:48 PM |
| Garber Alan M | Director | Feb 14, 2020 | Sale | $21.02 | 12,500 | 262,750 | 48,829 | Feb 14, 2020, 08:36 PM |
| SCANGOS GEORGE A | Director | Feb 12, 2020 | Sale | $20.02 | 21,000 | 420,420 | 1,013,031 | Feb 12, 2020, 08:21 PM |
| SCANGOS GEORGE A | Director | Feb 11, 2020 | Sale | $20.14 | 4,000 | 80,560 | 1,034,031 | Feb 12, 2020, 08:21 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 07, 2020 | Option Exercise | $5.51 | 50,000 | 275,500 | 375,122 | Feb 07, 2020, 08:43 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 07, 2020 | Sale | $18.37 | 50,000 | 918,500 | 325,122 | Feb 07, 2020, 08:43 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 29, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Jan 31, 2020, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 29, 2020 | Sale | $17.87 | 25,000 | 446,750 | 85,985 | Jan 31, 2020, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 23, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Jan 24, 2020, 08:19 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 23, 2020 | Sale | $19.41 | 25,000 | 485,250 | 85,985 | Jan 24, 2020, 08:19 PM |
| SCANGOS GEORGE A | Director | Jan 22, 2020 | Sale | $19.75 | 25,000 | 493,750 | 1,038,031 | Jan 24, 2020, 08:17 PM |
| MARCHESI VINCENT T | Director | Jan 15, 2020 | Sale | $20.01 | 61,683 | 1,234,277 | 82,484 | Jan 17, 2020, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 16, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Jan 17, 2020, 08:45 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 16, 2020 | Sale | $20.33 | 25,000 | 508,250 | 85,985 | Jan 17, 2020, 08:45 PM |
| SCANGOS GEORGE A | Director | Jan 15, 2020 | Sale | $20.39 | 25,000 | 509,750 | 1,063,031 | Jan 17, 2020, 08:42 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 08, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Jan 09, 2020, 08:35 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 08, 2020 | Sale | $18.85 | 25,000 | 471,250 | 85,985 | Jan 09, 2020, 08:35 PM |
| Garber Alan M | Director | Jan 07, 2020 | Option Exercise | $5.39 | 86,956 | 468,884 | 148,285 | Jan 09, 2020, 08:31 PM |
| Garber Alan M | Director | Jan 07, 2020 | Sale | $18.01 | 86,956 | 1,566,078 | 61,329 | Jan 09, 2020, 08:31 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jan 07, 2020 | Option Exercise | $5.51 | 50,000 | 275,500 | 375,122 | Jan 09, 2020, 08:27 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Jan 07, 2020 | Sale | $17.96 | 50,000 | 898,000 | 325,122 | Jan 09, 2020, 08:27 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 02, 2020 | Option Exercise | $5.51 | 25,000 | 137,750 | 110,985 | Jan 03, 2020, 07:46 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 02, 2020 | Sale | $17.49 | 25,000 | 437,250 | 85,985 | Jan 03, 2020, 07:46 PM |
| SCANGOS GEORGE A | Director | Dec 27, 2019 | Sale | $18.25 | 25,000 | 456,250 | 1,090,531 | Dec 27, 2019, 08:52 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Dec 04, 2019 | Option Exercise | $17.67 | 4,027 | 71,157 | 325,122 | Dec 06, 2019, 07:23 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Dec 04, 2019 | Option Exercise | $17.67 | 2,360 | 41,701 | 237,570 | Dec 06, 2019, 07:21 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 04, 2019 | Option Exercise | $17.67 | 3,872 | 68,418 | 126,531 | Dec 06, 2019, 07:18 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Dec 04, 2019 | Option Exercise | $17.67 | 2,007 | 35,464 | 86,191 | Dec 06, 2019, 07:16 PM |
| Senner Christopher J. | EVP and CFO | Dec 04, 2019 | Option Exercise | $17.67 | 4,090 | 72,270 | 120,703 | Dec 06, 2019, 07:13 PM |
| MORRISSEY MICHAEL | President and CEO | Dec 04, 2019 | Option Exercise | $17.67 | 9,788 | 172,954 | 214,114 | Dec 06, 2019, 07:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Dec 03, 2019 | Option Exercise | $5.51 | 50,000 | 275,500 | 363,557 | Dec 05, 2019, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Dec 03, 2019 | Sale | $16.22 | 50,000 | 811,000 | 313,557 | Dec 05, 2019, 08:11 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2019 | Option Exercise | $16.51 | 8,688 | 143,439 | 233,065 | Nov 15, 2019, 09:42 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 15, 2019 | Option Exercise | $16.51 | 12,268 | 202,545 | 316,140 | Nov 15, 2019, 09:39 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2019 | Option Exercise | $16.51 | 9,201 | 151,909 | 117,509 | Nov 15, 2019, 09:37 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2019 | Option Exercise | $16.51 | 18,428 | 304,246 | 194,619 | Nov 15, 2019, 09:34 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2019 | Option Exercise | $16.51 | 10,819 | 178,622 | 111,824 | Nov 15, 2019, 09:31 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Nov 15, 2019 | Option Exercise | $16.51 | 9,107 | 150,357 | 83,011 | Nov 15, 2019, 09:28 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 04, 2019 | Option Exercise | $5.51 | 50,000 | 275,500 | 374,331 | Nov 06, 2019, 07:55 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 04, 2019 | Sale | $15.99 | 50,000 | 799,500 | 324,331 | Nov 06, 2019, 07:55 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Oct 10, 2019 | Sale | $16.27 | 303 | 4,930 | 89,209 | Oct 11, 2019, 08:20 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 02, 2019 | Option Exercise | $7.18 | 35,409 | 254,237 | 231,513 | Oct 04, 2019, 08:02 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 02, 2019 | Sale | $17.66 | 26,364 | 465,588 | 205,149 | Oct 04, 2019, 08:02 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Oct 01, 2019 | Option Exercise | $5.51 | 30,000 | 165,300 | 354,331 | Oct 03, 2019, 09:03 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Oct 01, 2019 | Sale | $17.87 | 30,000 | 536,100 | 324,331 | Oct 03, 2019, 09:03 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 18, 2019 | Option Exercise | $7.18 | 50,000 | 359,000 | 233,331 | Sep 20, 2019, 08:05 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 18, 2019 | Sale | $19.20 | 37,227 | 714,758 | 196,104 | Sep 20, 2019, 08:05 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 12, 2019 | Option Exercise | $19.26 | 1,487 | 28,640 | 238,330 | Sep 13, 2019, 08:49 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sep 12, 2019 | Option Exercise | $19.26 | 2,581 | 49,710 | 124,611 | Sep 13, 2019, 08:47 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 12, 2019 | Option Exercise | $19.26 | 6,526 | 125,691 | 183,331 | Sep 13, 2019, 08:45 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Sep 12, 2019 | Option Exercise | $19.26 | 1,338 | 25,770 | 89,512 | Sep 13, 2019, 08:42 PM |
| Senner Christopher J. | EVP and CFO | Sep 12, 2019 | Option Exercise | $19.26 | 2,737 | 52,715 | 120,020 | Sep 13, 2019, 08:22 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sep 12, 2019 | Option Exercise | $19.26 | 2,577 | 49,633 | 324,331 | Sep 13, 2019, 08:13 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Sep 10, 2019 | Sale | $18.84 | 1,000 | 18,840 | 85,453 | Sep 12, 2019, 08:07 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Aug 16, 2019 | Option Exercise | $1.70 | 75,000 | 127,500 | 308,820 | Aug 20, 2019, 08:39 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Aug 16, 2019 | Sale | $21.10 | 75,000 | 1,582,500 | 233,820 | Aug 20, 2019, 08:39 PM |
| POSTE GEORGE | Director | Aug 16, 2019 | Option Exercise | $4.58 | 25,000 | 114,500 | 137,792 | Aug 19, 2019, 08:18 PM |
| POSTE GEORGE | Director | Aug 16, 2019 | Sale | $20.50 | 25,000 | 512,500 | 112,792 | Aug 19, 2019, 08:18 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 14, 2019 | Option Exercise | $7.18 | 50,000 | 359,000 | 200,109 | Aug 16, 2019, 08:02 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 14, 2019 | Sale | $20.11 | 35,040 | 704,654 | 165,069 | Aug 16, 2019, 08:02 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Aug 12, 2019 | Sale | $20.39 | 1,000 | 20,390 | 86,453 | Aug 14, 2019, 08:00 PM |
| POSTE GEORGE | Director | Aug 09, 2019 | Option Exercise | $5.59 | 20,000 | 111,700 | 132,792 | Aug 09, 2019, 07:55 PM |
| POSTE GEORGE | Director | Aug 09, 2019 | Sale | $20.60 | 20,000 | 412,000 | 112,792 | Aug 09, 2019, 07:55 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Aug 06, 2019 | Option Exercise | $1.70 | 25,000 | 42,500 | 112,453 | Aug 08, 2019, 08:13 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Aug 06, 2019 | Sale | $20.02 | 25,000 | 500,500 | 87,453 | Aug 08, 2019, 08:13 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 02, 2019 | Option Exercise | $7.18 | 50,000 | 359,000 | 185,149 | Aug 02, 2019, 08:29 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 02, 2019 | Sale | $20.25 | 35,040 | 709,560 | 150,109 | Aug 02, 2019, 08:29 PM |
| SCANGOS GEORGE A | Director | Aug 01, 2019 | Sale | $20.59 | 40,000 | 823,737 | 1,134,081 | Aug 02, 2019, 08:27 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 17, 2019 | Option Exercise | $7.18 | 50,000 | 359,000 | 169,870 | Jul 19, 2019, 08:04 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 17, 2019 | Sale | $21.37 | 34,721 | 741,988 | 135,149 | Jul 19, 2019, 08:04 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jul 10, 2019 | Sale | $20.96 | 1,000 | 20,960 | 87,453 | Jul 12, 2019, 07:53 PM |
| SCANGOS GEORGE A | Director | Jul 01, 2019 | Sale | $21.58 | 40,000 | 863,200 | 1,168,031 | Jul 03, 2019, 08:13 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 03, 2019 | Option Exercise | $7.18 | 50,000 | 359,000 | 154,591 | Jul 03, 2019, 08:11 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 03, 2019 | Sale | $21.03 | 34,721 | 730,183 | 119,870 | Jul 03, 2019, 08:11 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 18, 2019 | Option Exercise | $2.64 | 100,000 | 263,711 | 217,197 | Jun 19, 2019, 09:30 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2019 | Option Exercise | $5.38 | 100,000 | 538,259 | 217,197 | Jun 19, 2019, 09:30 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 19, 2019 | Option Exercise | $5.51 | 17,404 | 95,896 | 134,601 | Jun 19, 2019, 09:30 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2019 | Sale | $20.53 | 117,404 | 2,410,307 | 117,197 | Jun 19, 2019, 09:30 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 18, 2019 | Sale | $20.67 | 100,000 | 2,067,000 | 117,197 | Jun 19, 2019, 09:30 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 13, 2019 | Option Exercise | $5.56 | 27,596 | 153,434 | 144,793 | Jun 14, 2019, 08:11 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jun 13, 2019 | Sale | $20.03 | 27,596 | 552,748 | 117,197 | Jun 14, 2019, 08:11 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jun 10, 2019 | Sale | $20.23 | 1,000 | 20,230 | 88,453 | Jun 12, 2019, 08:16 PM |
| SCANGOS GEORGE A | Director | Jun 03, 2019 | Sale | $19.61 | 25,000 | 490,250 | 1,223,031 | Jun 05, 2019, 08:21 PM |
| SCANGOS GEORGE A | Director | Jun 04, 2019 | Sale | $20.00 | 15,000 | 300,000 | 1,208,031 | Jun 05, 2019, 08:21 PM |
| MORRISSEY MICHAEL | President and CEO | May 29, 2019 | Option Exercise | $7.18 | 14,591 | 104,763 | 104,591 | May 30, 2019, 08:53 PM |
| SCANGOS GEORGE A | Director | May 21, 2019 | Option Exercise | $4.57 | 15,000 | 68,550 | 1,248,031 | May 22, 2019, 08:52 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 10, 2019 | Sale | $19.58 | 1,000 | 19,580 | 89,453 | May 10, 2019, 08:35 PM |
| MORRISSEY MICHAEL | President and CEO | May 08, 2019 | Option Exercise | $5.56 | 42,000 | 233,520 | 132,000 | May 10, 2019, 08:21 PM |
| MORRISSEY MICHAEL | President and CEO | May 08, 2019 | Sale | $20.15 | 42,000 | 846,300 | 90,000 | May 10, 2019, 08:21 PM |
| WILLSEY LANCE | Director | May 08, 2019 | Sale | $20.36 | 50,000 | 1,018,000 | 368,273 | May 10, 2019, 08:20 PM |
| Senner Christopher J. | EVP and CFO | May 03, 2019 | Sale | $20.70 | 36,261 | 750,603 | 112,362 | May 03, 2019, 08:55 PM |
| SCANGOS GEORGE A | Director | May 02, 2019 | Sale | $20.00 | 15,000 | 300,000 | 1,233,031 | May 03, 2019, 08:52 PM |
| SCANGOS GEORGE A | Director | May 01, 2019 | Sale | $19.75 | 25,000 | 493,750 | 1,248,031 | May 03, 2019, 08:52 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 24, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Apr 26, 2019, 08:14 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 24, 2019 | Sale | $20.75 | 40,000 | 830,000 | 90,000 | Apr 26, 2019, 08:14 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Apr 10, 2019 | Sale | $24.04 | 1,000 | 24,040 | 88,780 | Apr 12, 2019, 07:59 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 10, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Apr 12, 2019, 07:56 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 10, 2019 | Sale | $24.06 | 40,000 | 962,400 | 90,000 | Apr 12, 2019, 07:56 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 03, 2019 | Option Exercise | $7.18 | 63,109 | 453,123 | 379,622 | Apr 03, 2019, 08:17 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Apr 03, 2019 | Sale | $25.00 | 63,109 | 1,577,725 | 316,513 | Apr 03, 2019, 08:17 PM |
| WYSZOMIERSKI JACK L | Director | Apr 01, 2019 | Option Exercise | $4.39 | 26,250 | 115,350 | 128,031 | Apr 03, 2019, 08:09 PM |
| WYSZOMIERSKI JACK L | Director | Apr 01, 2019 | Sale | $23.97 | 7,822 | 187,493 | 120,209 | Apr 03, 2019, 08:09 PM |
| SCANGOS GEORGE A | Director | Apr 03, 2019 | Sale | $25.03 | 5,000 | 125,150 | 1,273,031 | Apr 03, 2019, 08:05 PM |
| SCANGOS GEORGE A | Director | Apr 01, 2019 | Sale | $24.02 | 40,000 | 960,800 | 1,278,031 | Apr 03, 2019, 08:05 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Apr 01, 2019 | Option Exercise | $1.70 | 20,000 | 34,000 | 253,820 | Apr 03, 2019, 08:01 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Apr 01, 2019 | Sale | $24.03 | 20,000 | 480,600 | 233,820 | Apr 03, 2019, 08:01 PM |
| Garber Alan M | Director | Apr 01, 2019 | Option Exercise | $5.25 | 30,000 | 157,350 | 76,329 | Apr 03, 2019, 07:58 PM |
| Garber Alan M | Director | Apr 01, 2019 | Sale | $23.98 | 30,000 | 719,550 | 61,329 | Apr 03, 2019, 07:58 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 27, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Mar 29, 2019, 07:41 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 27, 2019 | Sale | $23.39 | 40,000 | 935,600 | 90,000 | Mar 29, 2019, 07:41 PM |
| POSTE GEORGE | Director | Mar 29, 2019 | Option Exercise | $4.57 | 15,000 | 68,550 | 106,335 | Mar 29, 2019, 07:37 PM |
| POSTE GEORGE | Director | Mar 29, 2019 | Sale | $23.89 | 3,860 | 92,215 | 102,475 | Mar 29, 2019, 07:37 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Mar 25, 2019 | Option Exercise | $7.18 | 100,000 | 718,000 | 416,513 | Mar 27, 2019, 08:33 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Mar 25, 2019 | Sale | $23.14 | 100,000 | 2,314,000 | 316,513 | Mar 27, 2019, 08:33 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 26, 2019 | Option Exercise | $5.18 | 2,700 | 13,986 | 92,480 | Mar 27, 2019, 08:31 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 26, 2019 | Sale | $23.47 | 2,700 | 63,369 | 89,780 | Mar 27, 2019, 08:31 PM |
| SCANGOS GEORGE A | Director | Mar 14, 2019 | Sale | $25.00 | 5,000 | 125,000 | 1,318,031 | Mar 15, 2019, 08:25 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 14, 2019 | Option Exercise | $1.76 | 2,000 | 3,520 | 91,780 | Mar 15, 2019, 08:10 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 14, 2019 | Sale | $25.00 | 2,000 | 50,000 | 89,780 | Mar 15, 2019, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 13, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Mar 15, 2019, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 13, 2019 | Sale | $24.64 | 40,000 | 985,485 | 118,367 | Mar 15, 2019, 08:07 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 11, 2019 | Sale | $23.13 | 959 | 22,182 | 89,780 | Mar 13, 2019, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 27, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Mar 01, 2019, 08:19 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 27, 2019 | Sale | $22.69 | 40,000 | 907,600 | 90,000 | Mar 01, 2019, 08:19 PM |
| SCANGOS GEORGE A | Director | Mar 01, 2019 | Sale | $22.66 | 40,000 | 906,400 | 1,323,031 | Mar 01, 2019, 08:17 PM |
| COHEN CHARLES | Director | Feb 25, 2019 | Option Exercise | $4.39 | 26,250 | 115,350 | 26,250 | Feb 27, 2019, 08:30 PM |
| COHEN CHARLES | Director | Feb 25, 2019 | Sale | $22.18 | 5,271 | 116,911 | 20,979 | Feb 27, 2019, 08:30 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Feb 25, 2019 | Sale | $22.27 | 4,272 | 95,137 | 90,739 | Feb 27, 2019, 08:28 PM |
| PAPADOPOULOS STELIOS | Director | Feb 21, 2019 | Option Exercise | $4.39 | 26,250 | 115,350 | 1,068,501 | Feb 22, 2019, 07:35 PM |
| PAPADOPOULOS STELIOS | Director | Feb 21, 2019 | Sale | $21.25 | 26,250 | 557,813 | 1,042,251 | Feb 22, 2019, 07:35 PM |
| WILLSEY LANCE | Director | Feb 20, 2019 | Option Exercise | $4.39 | 26,250 | 115,350 | 444,523 | Feb 22, 2019, 07:33 PM |
| WILLSEY LANCE | Director | Feb 20, 2019 | Sale | $21.11 | 26,250 | 554,138 | 418,273 | Feb 22, 2019, 07:33 PM |
| MARCHESI VINCENT T | Director | Feb 22, 2019 | Option Exercise | $4.95 | 41,250 | 204,150 | 175,100 | Feb 22, 2019, 07:32 PM |
| MARCHESI VINCENT T | Director | Feb 22, 2019 | Sale | $21.50 | 41,250 | 886,875 | 133,850 | Feb 22, 2019, 07:32 PM |
| COHEN CHARLES | Director | Feb 15, 2019 | Sale | $22.19 | 100,000 | 2,219,000 | 48,180 | Feb 19, 2019, 08:10 PM |
| COHEN CHARLES | Director | Feb 14, 2019 | Sale | $22.41 | 100,000 | 2,241,000 | 148,180 | Feb 19, 2019, 08:10 PM |
| COHEN CHARLES | Director | Feb 19, 2019 | Sale | $21.48 | 48,180 | 1,034,906 | 0 | Feb 19, 2019, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 14, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Feb 15, 2019, 08:14 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 14, 2019 | Sale | $22.39 | 40,000 | 895,654 | 90,200 | Feb 15, 2019, 08:14 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 15, 2019 | Option Exercise | $5.56 | 23,000 | 127,880 | 339,513 | Feb 15, 2019, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 14, 2019 | Option Exercise | $5.56 | 100,000 | 556,000 | 416,513 | Feb 15, 2019, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 15, 2019 | Sale | $22.20 | 23,000 | 510,600 | 316,513 | Feb 15, 2019, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Feb 14, 2019 | Sale | $21.66 | 100,000 | 2,166,000 | 316,513 | Feb 15, 2019, 08:11 PM |
| FELDBAUM CARL B | Director | Feb 14, 2019 | Option Exercise | $4.98 | 50,500 | 251,275 | 65,721 | Feb 15, 2019, 08:06 PM |
| FELDBAUM CARL B | Director | Feb 14, 2019 | Sale | $22.03 | 50,500 | 1,112,515 | 15,221 | Feb 15, 2019, 08:06 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Feb 11, 2019 | Sale | $21.30 | 1,000 | 21,300 | 95,011 | Feb 13, 2019, 08:36 PM |
| SCANGOS GEORGE A | Director | Feb 01, 2019 | Sale | $23.53 | 40,000 | 941,200 | 1,363,031 | Feb 01, 2019, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 30, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Feb 01, 2019, 07:58 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 30, 2019 | Sale | $23.12 | 40,000 | 924,800 | 90,000 | Feb 01, 2019, 07:58 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 16, 2019 | Option Exercise | $5.56 | 40,000 | 222,400 | 130,000 | Jan 18, 2019, 08:16 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 16, 2019 | Sale | $23.29 | 40,000 | 931,456 | 90,400 | Jan 18, 2019, 08:16 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 10, 2019 | Option Exercise | $1.76 | 2,000 | 3,520 | 99,011 | Jan 11, 2019, 07:56 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 10, 2019 | Sale | $23.85 | 3,000 | 71,540 | 97,011 | Jan 11, 2019, 07:56 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 09, 2019 | Option Exercise | $5.82 | 1,560 | 9,079 | 98,571 | Jan 09, 2019, 07:49 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 08, 2019 | Option Exercise | $1.76 | 2,000 | 3,520 | 99,011 | Jan 09, 2019, 07:49 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 07, 2019 | Option Exercise | $2.90 | 5,560 | 16,119 | 101,011 | Jan 09, 2019, 07:49 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 08, 2019 | Sale | $23.00 | 2,000 | 46,000 | 97,011 | Jan 09, 2019, 07:49 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 07, 2019 | Sale | $21.51 | 5,560 | 119,620 | 97,011 | Jan 09, 2019, 07:49 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 09, 2019 | Sale | $23.50 | 1,560 | 36,660 | 97,011 | Jan 09, 2019, 07:49 PM |
| Garber Alan M | Director | Jan 08, 2019 | Option Exercise | $4.16 | 11,250 | 46,800 | 72,579 | Jan 09, 2019, 07:47 PM |
| Garber Alan M | Director | Jan 08, 2019 | Sale | $23.00 | 11,250 | 258,750 | 61,329 | Jan 09, 2019, 07:47 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 04, 2019 | Option Exercise | $5.56 | 30,383 | 168,929 | 120,383 | Jan 04, 2019, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 03, 2019 | Option Exercise | $5.56 | 3,571 | 19,855 | 93,571 | Jan 04, 2019, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 02, 2019 | Option Exercise | $5.56 | 6,046 | 33,616 | 96,046 | Jan 04, 2019, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 04, 2019 | Sale | $20.14 | 30,383 | 611,914 | 90,000 | Jan 04, 2019, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 03, 2019 | Sale | $20.00 | 3,571 | 71,420 | 90,000 | Jan 04, 2019, 08:50 PM |
| MORRISSEY MICHAEL | President and CEO | Jan 02, 2019 | Sale | $20.00 | 6,046 | 120,920 | 90,000 | Jan 04, 2019, 08:50 PM |
| SCANGOS GEORGE A | Director | Jan 03, 2019 | Sale | $20.00 | 96 | 1,920 | 1,403,031 | Jan 04, 2019, 08:18 PM |
| SCANGOS GEORGE A | Director | Jan 02, 2019 | Sale | $19.64 | 39,904 | 783,715 | 1,403,127 | Jan 04, 2019, 08:18 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 03, 2019 | Option Exercise | $1.76 | 8,000 | 14,080 | 105,011 | Jan 04, 2019, 08:15 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Jan 03, 2019 | Sale | $19.95 | 8,000 | 159,600 | 97,011 | Jan 04, 2019, 08:15 PM |
| SCANGOS GEORGE A | Director | Dec 03, 2018 | Sale | $21.16 | 40,000 | 846,400 | 1,456,981 | Dec 03, 2018, 08:03 PM |
| SCANGOS GEORGE A | Director | Nov 30, 2018 | Sale | $20.00 | 8,500 | 170,000 | 1,496,981 | Dec 03, 2018, 08:03 PM |
| SCANGOS GEORGE A | Director | Nov 29, 2018 | Sale | $20.00 | 6,500 | 130,000 | 1,505,481 | Dec 03, 2018, 08:03 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Dec 03, 2018 | Option Exercise | $5.04 | 13,499 | 68,035 | 330,012 | Dec 03, 2018, 08:00 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Dec 03, 2018 | Sale | $21.02 | 13,499 | 283,749 | 316,513 | Dec 03, 2018, 08:00 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 30, 2018 | Sale | $19.91 | 1,943 | 38,685 | 233,820 | Nov 30, 2018, 08:02 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 29, 2018 | Sale | $19.51 | 1,116 | 21,773 | 235,763 | Nov 30, 2018, 08:02 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 28, 2018 | Sale | $19.12 | 11,759 | 224,832 | 236,879 | Nov 30, 2018, 08:02 PM |
| Senner Christopher J. | EVP and CFO | Nov 30, 2018 | Sale | $19.70 | 8,791 | 173,183 | 146,950 | Nov 30, 2018, 08:00 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2018 | Option Exercise | $17.45 | 7,764 | 135,482 | 157,623 | Nov 16, 2018, 08:26 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 15, 2018 | Option Exercise | $17.45 | 11,775 | 205,474 | 318,992 | Nov 16, 2018, 08:24 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2018 | Option Exercise | $17.45 | 17,353 | 302,810 | 115,084 | Nov 16, 2018, 08:22 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2018 | Option Exercise | $4.42 | 25,000 | 110,500 | 132,647 | Nov 16, 2018, 08:22 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2018 | Sale | $17.22 | 25,000 | 430,500 | 107,647 | Nov 16, 2018, 08:22 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2018 | Option Exercise | $17.45 | 9,199 | 160,523 | 119,295 | Nov 16, 2018, 08:19 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2018 | Option Exercise | $17.45 | 5,812 | 101,419 | 250,042 | Nov 16, 2018, 08:16 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Nov 15, 2018 | Option Exercise | $17.45 | 9,106 | 158,900 | 99,920 | Nov 16, 2018, 08:12 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Nov 07, 2018 | Sale | $17.32 | 20,000 | 346,400 | 104,917 | Nov 09, 2018, 07:56 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 01, 2018 | Option Exercise | $5.04 | 12,000 | 60,480 | 340,288 | Nov 02, 2018, 08:05 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Nov 01, 2018 | Sale | $14.16 | 12,000 | 169,920 | 328,288 | Nov 02, 2018, 08:05 PM |
| SCANGOS GEORGE A | Director | Nov 01, 2018 | Sale | $14.66 | 25,000 | 366,400 | 1,521,981 | Nov 02, 2018, 08:03 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 02, 2018 | Option Exercise | $5.04 | 37,499 | 188,995 | 162,499 | Nov 02, 2018, 08:02 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 02, 2018 | Sale | $17.57 | 37,499 | 658,964 | 129,144 | Nov 02, 2018, 08:02 PM |
| SCANGOS GEORGE A | Director | Oct 01, 2018 | Sale | $17.86 | 25,000 | 446,500 | 1,536,981 | Oct 03, 2018, 08:12 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 01, 2018 | Option Exercise | $5.04 | 12,501 | 63,005 | 137,501 | Oct 03, 2018, 08:11 PM |
| MORRISSEY MICHAEL | President and CEO | Oct 01, 2018 | Sale | $17.82 | 12,501 | 222,768 | 125,000 | Oct 03, 2018, 08:11 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Oct 01, 2018 | Option Exercise | $5.04 | 12,000 | 60,480 | 340,288 | Oct 03, 2018, 08:08 PM |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Oct 01, 2018 | Sale | $17.77 | 12,000 | 213,240 | 328,288 | Oct 03, 2018, 08:08 PM |
| SCANGOS GEORGE A | Director | Sep 24, 2018 | Sale | $16.85 | 25,000 | 421,250 | 1,561,981 | Sep 26, 2018, 07:40 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 04, 2018 | Option Exercise | $5.50 | 22,500 | 123,750 | 350,788 | Sep 06, 2018, 08:00 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 04, 2018 | Sale | $18.53 | 22,500 | 416,925 | 328,288 | Sep 06, 2018, 08:00 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 20, 2018 | Option Exercise | $5.50 | 90,000 | 495,000 | 215,000 | Aug 22, 2018, 08:10 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 20, 2018 | Sale | $17.82 | 90,000 | 1,604,216 | 211,200 | Aug 22, 2018, 08:10 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 17, 2018 | Option Exercise | $5.51 | 50,000 | 275,500 | 328,288 | Aug 20, 2018, 08:10 PM |
| MARCHESI VINCENT T | Director | Aug 15, 2018 | Option Exercise | $3.38 | 40,000 | 135,200 | 173,850 | Aug 17, 2018, 07:39 PM |
| MARCHESI VINCENT T | Director | Aug 15, 2018 | Sale | $19.50 | 40,000 | 780,000 | 133,850 | Aug 17, 2018, 07:39 PM |
| SCANGOS GEORGE A | Director | Aug 10, 2018 | Option Exercise | $4.85 | 108,333 | 525,332 | 1,586,981 | Aug 10, 2018, 09:25 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 07, 2018 | Option Exercise | $1.70 | 100,000 | 170,000 | 225,000 | Aug 09, 2018, 07:35 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 09, 2018 | Option Exercise | $1.70 | 34,267 | 58,254 | 159,267 | Aug 09, 2018, 07:35 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 08, 2018 | Option Exercise | $1.70 | 100,000 | 170,000 | 225,000 | Aug 09, 2018, 07:35 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 07, 2018 | Sale | $21.10 | 100,000 | 2,110,000 | 125,000 | Aug 09, 2018, 07:35 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 09, 2018 | Sale | $20.91 | 34,267 | 716,523 | 125,000 | Aug 09, 2018, 07:35 PM |
| MORRISSEY MICHAEL | President and CEO | Aug 08, 2018 | Sale | $21.02 | 100,000 | 2,102,000 | 125,000 | Aug 09, 2018, 07:35 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Aug 06, 2018 | Sale | $20.92 | 2,361 | 49,392 | 124,917 | Aug 08, 2018, 07:26 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 01, 2018 | Option Exercise | $5.50 | 22,500 | 123,750 | 300,788 | Aug 03, 2018, 07:13 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 01, 2018 | Sale | $20.56 | 22,500 | 462,600 | 278,288 | Aug 03, 2018, 07:13 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 16, 2018 | Option Exercise | $5.50 | 90,000 | 495,000 | 215,000 | Jul 17, 2018, 08:19 PM |
| MORRISSEY MICHAEL | President and CEO | Jul 16, 2018 | Sale | $21.13 | 90,000 | 1,901,700 | 125,000 | Jul 17, 2018, 08:19 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Jul 02, 2018 | Option Exercise | $5.50 | 22,500 | 123,750 | 300,788 | Jul 03, 2018, 09:07 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Jul 02, 2018 | Sale | $21.20 | 22,500 | 477,000 | 278,288 | Jul 03, 2018, 09:07 PM |
| MORRISSEY MICHAEL | President and CEO | Jun 25, 2018 | Option Exercise | $5.50 | 90,000 | 495,000 | 215,000 | Jun 27, 2018, 08:12 PM |
| MORRISSEY MICHAEL | President and CEO | Jun 25, 2018 | Sale | $19.62 | 90,000 | 1,765,800 | 125,000 | Jun 27, 2018, 08:12 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 31, 2018 | Sale | $20.71 | 65,000 | 1,346,150 | 254,450 | Jun 01, 2018, 08:00 PM |
| FELDBAUM CARL B | Director | May 30, 2018 | Option Exercise | $4.26 | 14,750 | 62,795 | 49,483 | Jun 01, 2018, 07:59 PM |
| FELDBAUM CARL B | Director | May 30, 2018 | Sale | $20.60 | 34,262 | 705,797 | 15,221 | Jun 01, 2018, 07:59 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Jun 01, 2018 | Option Exercise | $5.50 | 22,500 | 123,750 | 300,788 | Jun 01, 2018, 07:58 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Jun 01, 2018 | Sale | $20.80 | 22,500 | 468,000 | 278,288 | Jun 01, 2018, 07:58 PM |
| WILLSEY LANCE | Director | May 22, 2018 | Sale | $21.40 | 50,000 | 1,070,000 | 418,273 | May 24, 2018, 08:24 PM |
| MORRISSEY MICHAEL | President and CEO | May 24, 2018 | Option Exercise | $5.50 | 90,000 | 495,000 | 215,000 | May 24, 2018, 08:16 PM |
| MORRISSEY MICHAEL | President and CEO | May 24, 2018 | Sale | $20.55 | 90,000 | 1,849,500 | 125,000 | May 24, 2018, 08:16 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 18, 2018 | Sale | $21.61 | 3,663 | 79,157 | 127,278 | May 18, 2018, 08:02 PM |
| SCANGOS GEORGE A | Director | May 15, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 1,478,648 | May 16, 2018, 07:59 PM |
| MARCHESI VINCENT T | Director | May 11, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 140,913 | May 11, 2018, 07:58 PM |
| MARCHESI VINCENT T | Director | May 11, 2018 | Sale | $19.03 | 15,000 | 285,450 | 125,913 | May 11, 2018, 07:58 PM |
| COHEN CHARLES | Director | May 09, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 263,180 | May 10, 2018, 08:03 PM |
| COHEN CHARLES | Director | May 09, 2018 | Sale | $21.42 | 15,000 | 321,300 | 248,180 | May 10, 2018, 08:03 PM |
| PAPADOPOULOS STELIOS | Director | May 07, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 1,049,314 | May 07, 2018, 08:07 PM |
| PAPADOPOULOS STELIOS | Director | May 07, 2018 | Sale | $22.15 | 15,000 | 332,250 | 1,034,314 | May 07, 2018, 08:07 PM |
| Hessekiel Jeffrey | EVP and General Counsel | May 04, 2018 | Sale | $22.36 | 20,000 | 447,200 | 319,450 | May 07, 2018, 08:07 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 07, 2018 | Option Exercise | $1.90 | 15,000 | 28,500 | 145,941 | May 07, 2018, 08:06 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 04, 2018 | Option Exercise | $1.90 | 10,000 | 19,000 | 143,490 | May 07, 2018, 08:06 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 07, 2018 | Sale | $22.00 | 15,000 | 330,000 | 130,941 | May 07, 2018, 08:06 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 04, 2018 | Sale | $22.38 | 12,549 | 280,847 | 130,941 | May 07, 2018, 08:06 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | May 03, 2018 | Option Exercise | $5.50 | 22,500 | 123,750 | 300,788 | May 04, 2018, 07:06 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | May 03, 2018 | Sale | $23.09 | 22,500 | 519,417 | 292,988 | May 04, 2018, 07:06 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Apr 27, 2018 | Option Exercise | $1.70 | 25,000 | 42,500 | 339,450 | Apr 30, 2018, 08:23 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Apr 24, 2018 | Option Exercise | $1.70 | 20,000 | 34,000 | 133,490 | Apr 26, 2018, 08:22 PM |
| WYSZOMIERSKI JACK L | Director | Apr 16, 2018 | Option Exercise | $9.81 | 30,000 | 294,450 | 108,803 | Apr 18, 2018, 08:12 PM |
| WYSZOMIERSKI JACK L | Director | Apr 16, 2018 | Sale | $20.25 | 14,959 | 302,920 | 93,844 | Apr 18, 2018, 08:12 PM |
| Garber Alan M | Director | Apr 16, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 76,329 | Apr 18, 2018, 08:11 PM |
| Garber Alan M | Director | Apr 16, 2018 | Sale | $20.25 | 15,000 | 303,750 | 61,329 | Apr 18, 2018, 08:11 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 11, 2018 | Option Exercise | $5.50 | 90,000 | 495,000 | 221,653 | Apr 13, 2018, 08:09 PM |
| MORRISSEY MICHAEL | President and CEO | Apr 11, 2018 | Sale | $20.78 | 90,000 | 1,870,200 | 131,653 | Apr 13, 2018, 08:09 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Apr 06, 2018 | Option Exercise | $7.18 | 14,591 | 104,763 | 277,280 | Apr 06, 2018, 07:48 PM |
| FELDBAUM CARL B | Director | Mar 05, 2018 | Option Exercise | $11.66 | 11,000 | 128,260 | 45,733 | Mar 07, 2018, 07:26 PM |
| FELDBAUM CARL B | Director | Mar 05, 2018 | Sale | $23.88 | 11,000 | 262,680 | 34,733 | Mar 07, 2018, 07:26 PM |
| COHEN CHARLES | Director | Mar 05, 2018 | Option Exercise | $7.97 | 15,000 | 119,550 | 263,180 | Mar 07, 2018, 07:25 PM |
| COHEN CHARLES | Director | Mar 05, 2018 | Sale | $24.23 | 15,000 | 363,450 | 248,180 | Mar 07, 2018, 07:25 PM |
| MARCHESI VINCENT T | Director | Mar 06, 2018 | Option Exercise | $7.97 | 15,000 | 119,550 | 140,913 | Mar 07, 2018, 07:23 PM |
| MARCHESI VINCENT T | Director | Mar 06, 2018 | Sale | $24.73 | 15,000 | 370,950 | 125,913 | Mar 07, 2018, 07:23 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Mar 01, 2018 | Option Exercise | $4.42 | 7,293 | 32,235 | 262,689 | Mar 02, 2018, 08:04 PM |
| PAPADOPOULOS STELIOS | Director | Mar 02, 2018 | Option Exercise | $7.97 | 15,000 | 119,550 | 1,049,314 | Mar 02, 2018, 08:03 PM |
| PAPADOPOULOS STELIOS | Director | Mar 02, 2018 | Sale | $24.05 | 15,000 | 360,750 | 1,034,314 | Mar 02, 2018, 08:03 PM |
| WILLSEY LANCE | Director | Mar 02, 2018 | Option Exercise | $9.81 | 30,000 | 294,450 | 498,273 | Mar 02, 2018, 08:01 PM |
| WILLSEY LANCE | Director | Mar 02, 2018 | Sale | $23.91 | 30,000 | 717,300 | 468,273 | Mar 02, 2018, 08:01 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Feb 28, 2018 | Option Exercise | $2.58 | 13,625 | 35,200 | 158,519 | Mar 02, 2018, 08:00 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Feb 28, 2018 | Sale | $27.13 | 45,029 | 1,221,637 | 113,490 | Mar 02, 2018, 08:00 PM |
| POSTE GEORGE | Director | Feb 28, 2018 | Option Exercise | $11.66 | 15,000 | 174,900 | 98,398 | Mar 02, 2018, 07:59 PM |
| POSTE GEORGE | Director | Feb 28, 2018 | Sale | $26.26 | 15,000 | 393,900 | 83,398 | Mar 02, 2018, 07:59 PM |
| Garber Alan M | Director | Jan 09, 2018 | Option Exercise | $7.97 | 11,500 | 91,655 | 72,829 | Jan 10, 2018, 07:27 PM |
| Garber Alan M | Director | Jan 08, 2018 | Option Exercise | $7.97 | 3,500 | 27,895 | 64,829 | Jan 10, 2018, 07:27 PM |
| Garber Alan M | Director | Jan 08, 2018 | Sale | $31.29 | 3,500 | 109,515 | 61,329 | Jan 10, 2018, 07:27 PM |
| Garber Alan M | Director | Jan 09, 2018 | Sale | $30.00 | 11,500 | 345,000 | 61,329 | Jan 10, 2018, 07:27 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2017 | Option Exercise | $24.75 | 2,204 | 54,549 | 126,396 | Nov 17, 2017, 07:47 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Nov 15, 2017 | Option Exercise | $24.75 | 2,609 | 64,573 | 255,396 | Nov 17, 2017, 07:47 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Nov 15, 2017 | Option Exercise | $24.75 | 3,739 | 92,540 | 91,709 | Nov 17, 2017, 07:46 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Nov 15, 2017 | Option Exercise | $24.75 | 2,120 | 52,470 | 316,942 | Nov 17, 2017, 07:45 PM |
| Senner Christopher J. | EVP and CFO | Nov 15, 2017 | Option Exercise | $24.75 | 2,762 | 68,360 | 162,497 | Nov 17, 2017, 07:44 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 15, 2017 | Option Exercise | $24.75 | 8,347 | 206,588 | 131,653 | Nov 17, 2017, 07:43 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 27, 2017 | Option Exercise | $1.90 | 2,302 | 4,374 | 270,248 | Sep 28, 2017, 07:47 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 28, 2017 | Option Exercise | $1.90 | 25,000 | 47,500 | 292,946 | Sep 28, 2017, 07:47 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 28, 2017 | Sale | $24.32 | 25,000 | 608,000 | 267,946 | Sep 28, 2017, 07:47 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Sep 27, 2017 | Sale | $23.90 | 2,302 | 55,018 | 267,946 | Sep 28, 2017, 07:47 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 28, 2017 | Option Exercise | $9.91 | 33,334 | 330,340 | 216,339 | Sep 28, 2017, 07:45 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 27, 2017 | Option Exercise | $9.91 | 33,333 | 330,330 | 216,338 | Sep 28, 2017, 07:45 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 26, 2017 | Option Exercise | $9.91 | 33,333 | 330,330 | 216,338 | Sep 28, 2017, 07:45 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 28, 2017 | Sale | $23.74 | 33,334 | 791,349 | 183,005 | Sep 28, 2017, 07:45 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 27, 2017 | Sale | $23.94 | 33,333 | 797,992 | 183,005 | Sep 28, 2017, 07:45 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Sep 26, 2017 | Sale | $23.68 | 33,333 | 789,325 | 183,005 | Sep 28, 2017, 07:45 PM |
| PAPADOPOULOS STELIOS | Director | Sep 22, 2017 | Sale | $25.40 | 10,000 | 254,000 | 0 | Sep 22, 2017, 07:07 PM |
| PAPADOPOULOS STELIOS | Director | Sep 19, 2017 | Sale | $27.63 | 127,790 | 3,530,838 | 1,034,314 | Sep 20, 2017, 06:48 PM |
| PAPADOPOULOS STELIOS | Director | Sep 18, 2017 | Sale | $27.76 | 72,210 | 2,004,550 | 1,162,104 | Sep 20, 2017, 06:48 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Sep 14, 2017 | Sale | $27.21 | 60,640 | 1,650,014 | 41,553 | Sep 15, 2017, 06:43 PM |
| WILLSEY LANCE | Director | Sep 13, 2017 | Sale | $26.97 | 50,000 | 1,348,500 | 468,273 | Sep 14, 2017, 07:18 PM |
| WILLSEY LANCE | Director | Sep 12, 2017 | Sale | $26.79 | 50,000 | 1,339,500 | 518,273 | Sep 14, 2017, 07:18 PM |
| Senner Christopher J. | EVP and CFO | Sep 12, 2017 | Option Exercise | $3.66 | 100,000 | 366,000 | 202,759 | Sep 14, 2017, 07:17 PM |
| Senner Christopher J. | EVP and CFO | Sep 12, 2017 | Sale | $26.79 | 100,000 | 2,679,000 | 102,759 | Sep 14, 2017, 07:17 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 12, 2017 | Option Exercise | $1.70 | 100,000 | 170,000 | 160,000 | Sep 14, 2017, 07:14 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 14, 2017 | Option Exercise | $1.70 | 100,000 | 170,000 | 160,000 | Sep 14, 2017, 07:14 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 13, 2017 | Option Exercise | $1.70 | 100,000 | 170,000 | 160,000 | Sep 14, 2017, 07:14 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 14, 2017 | Sale | $27.08 | 100,000 | 2,708,000 | 60,000 | Sep 14, 2017, 07:14 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 13, 2017 | Sale | $27.04 | 100,000 | 2,704,000 | 60,000 | Sep 14, 2017, 07:14 PM |
| MORRISSEY MICHAEL | President and CEO | Sep 12, 2017 | Sale | $26.59 | 100,000 | 2,659,000 | 60,000 | Sep 14, 2017, 07:14 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | May 30, 2017 | Sale | $18.46 | 5,000 | 92,300 | 102,193 | Jun 01, 2017, 07:09 PM |
| FELDBAUM CARL B | Director | May 15, 2017 | Option Exercise | $8.75 | 19,000 | 166,190 | 67,721 | May 16, 2017, 09:13 PM |
| FELDBAUM CARL B | Director | May 15, 2017 | Sale | $21.58 | 32,988 | 711,831 | 48,721 | May 16, 2017, 09:13 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | May 15, 2017 | Option Exercise | $5.04 | 12,501 | 63,005 | 183,005 | May 16, 2017, 09:12 PM |
| MORRISSEY MICHAEL | President and CEO | May 09, 2017 | Option Exercise | $1.90 | 100,000 | 190,000 | 111,214 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 08, 2017 | Option Exercise | $1.90 | 11,300 | 21,470 | 71,300 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 10, 2017 | Option Exercise | $1.86 | 100,000 | 185,910 | 160,000 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 09, 2017 | Sale | $21.69 | 100,000 | 2,168,706 | 60,000 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 08, 2017 | Sale | $21.81 | 11,300 | 246,453 | 60,000 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 10, 2017 | Sale | $22.07 | 100,000 | 2,207,000 | 60,000 | May 10, 2017, 08:07 PM |
| MORRISSEY MICHAEL | President and CEO | May 04, 2017 | Option Exercise | $1.90 | 59,149 | 112,383 | 119,149 | May 05, 2017, 06:53 PM |
| MORRISSEY MICHAEL | President and CEO | May 03, 2017 | Option Exercise | $1.90 | 100,000 | 190,000 | 129,427 | May 05, 2017, 06:53 PM |
| MORRISSEY MICHAEL | President and CEO | May 05, 2017 | Option Exercise | $1.90 | 100,000 | 190,000 | 149,555 | May 05, 2017, 06:53 PM |
| MORRISSEY MICHAEL | President and CEO | May 04, 2017 | Sale | $22.17 | 59,149 | 1,311,333 | 60,000 | May 05, 2017, 06:53 PM |
| MORRISSEY MICHAEL | President and CEO | May 03, 2017 | Sale | $22.67 | 100,000 | 2,266,803 | 60,000 | May 05, 2017, 06:53 PM |
| MORRISSEY MICHAEL | President and CEO | May 05, 2017 | Sale | $21.85 | 100,000 | 2,184,702 | 60,000 | May 05, 2017, 06:53 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | May 01, 2017 | Option Exercise | $9.91 | 89,910 | 891,008 | 260,414 | May 03, 2017, 08:02 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | May 01, 2017 | Sale | $23.01 | 89,910 | 2,068,519 | 172,404 | May 03, 2017, 08:02 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Apr 17, 2017 | Option Exercise | $9.91 | 10,090 | 99,992 | 168,143 | Apr 18, 2017, 07:57 PM |
| MARCHESI VINCENT T | Director | Apr 03, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 130,070 | Apr 04, 2017, 08:00 PM |
| MARCHESI VINCENT T | Director | Apr 03, 2017 | Sale | $21.30 | 10,000 | 213,000 | 120,070 | Apr 04, 2017, 08:00 PM |
| WYSZOMIERSKI JACK L | Director | Mar 31, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 78,110 | Mar 31, 2017, 06:35 PM |
| WYSZOMIERSKI JACK L | Director | Mar 31, 2017 | Sale | $21.57 | 5,150 | 111,085 | 72,960 | Mar 31, 2017, 06:35 PM |
| COHEN CHARLES | Director | Mar 27, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 248,180 | Mar 28, 2017, 08:15 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Mar 27, 2017 | Sale | $21.02 | 6,884 | 144,702 | 267,946 | Mar 28, 2017, 08:15 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Mar 22, 2017 | Option Exercise | $1.70 | 55,000 | 93,500 | 301,617 | Mar 24, 2017, 07:41 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Mar 22, 2017 | Sale | $20.54 | 23,787 | 488,585 | 277,830 | Mar 24, 2017, 07:41 PM |
| FELDBAUM CARL B | Director | Mar 20, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 58,721 | Mar 21, 2017, 07:29 PM |
| FELDBAUM CARL B | Director | Mar 20, 2017 | Sale | $21.77 | 10,000 | 217,700 | 48,721 | Mar 21, 2017, 07:29 PM |
| PAPADOPOULOS STELIOS | Director | Mar 20, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 1,238,471 | Mar 21, 2017, 07:28 PM |
| PAPADOPOULOS STELIOS | Director | Mar 20, 2017 | Sale | $21.66 | 10,000 | 216,600 | 1,228,471 | Mar 21, 2017, 07:28 PM |
| WILLSEY LANCE | Director | Mar 15, 2017 | Option Exercise | $10.53 | 10,000 | 105,300 | 578,273 | Mar 17, 2017, 07:52 PM |
| WILLSEY LANCE | Director | Mar 15, 2017 | Sale | $22.86 | 10,000 | 228,600 | 568,273 | Mar 17, 2017, 07:52 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Mar 15, 2017 | Option Exercise | $6.20 | 50,007 | 310,179 | 208,060 | Mar 17, 2017, 07:51 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Mar 15, 2017 | Sale | $22.53 | 50,007 | 1,126,658 | 158,053 | Mar 17, 2017, 07:51 PM |
| COHEN CHARLES | Director | Mar 13, 2017 | Sale | $21.82 | 10,000 | 218,200 | 238,180 | Mar 14, 2017, 08:12 PM |
| MARCHESI VINCENT T | Director | Mar 10, 2017 | Option Exercise | $3.13 | 40,000 | 125,200 | 160,070 | Mar 10, 2017, 07:37 PM |
| MARCHESI VINCENT T | Director | Mar 10, 2017 | Sale | $21.98 | 40,000 | 879,200 | 120,070 | Mar 10, 2017, 07:37 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Mar 03, 2017 | Option Exercise | $7.27 | 100,000 | 727,000 | 346,617 | Mar 07, 2017, 08:00 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Mar 03, 2017 | Sale | $23.04 | 100,000 | 2,303,678 | 309,618 | Mar 07, 2017, 08:00 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 06, 2017 | Option Exercise | $9.91 | 100,000 | 991,000 | 160,000 | Mar 07, 2017, 07:56 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 03, 2017 | Option Exercise | $9.91 | 100,000 | 991,000 | 160,000 | Mar 07, 2017, 07:56 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 06, 2017 | Sale | $22.61 | 100,000 | 2,261,000 | 60,000 | Mar 07, 2017, 07:56 PM |
| MORRISSEY MICHAEL | President and CEO | Mar 03, 2017 | Sale | $22.83 | 100,000 | 2,283,000 | 60,000 | Mar 07, 2017, 07:56 PM |
| Haley Patrick J. | Sr. Vice President, Commercial | Mar 03, 2017 | Sale | $23.04 | 2,500 | 57,600 | 107,193 | Mar 07, 2017, 07:45 PM |
| Senner Christopher J. | EVP and CFO | Mar 03, 2017 | Sale | $22.80 | 11,000 | 250,800 | 100,398 | Mar 03, 2017, 08:20 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2017 | Option Exercise | $7.36 | 45,000 | 331,350 | 118,600 | Mar 03, 2017, 08:18 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2017 | Sale | $22.19 | 45,000 | 998,550 | 73,600 | Mar 03, 2017, 08:18 PM |
| POSTE GEORGE | Director | Mar 01, 2017 | Option Exercise | $10.53 | 8,850 | 93,190 | 86,405 | Mar 03, 2017, 08:17 PM |
| POSTE GEORGE | Director | Mar 02, 2017 | Option Exercise | $4.51 | 67,400 | 303,659 | 144,955 | Mar 03, 2017, 08:17 PM |
| POSTE GEORGE | Director | Mar 02, 2017 | Sale | $22.58 | 67,400 | 1,521,892 | 77,555 | Mar 03, 2017, 08:17 PM |
| POSTE GEORGE | Director | Mar 01, 2017 | Sale | $22.18 | 8,850 | 196,293 | 77,555 | Mar 03, 2017, 08:17 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2017 | Option Exercise | $6.92 | 70,000 | 484,300 | 143,600 | Feb 03, 2017, 07:55 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2017 | Sale | $18.65 | 70,000 | 1,305,500 | 73,600 | Feb 03, 2017, 07:55 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jan 03, 2017 | Option Exercise | $5.74 | 70,000 | 401,800 | 143,600 | Jan 05, 2017, 08:25 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Jan 03, 2017 | Sale | $14.65 | 70,000 | 1,025,636 | 76,000 | Jan 05, 2017, 08:25 PM |
| FELDBAUM CARL B | Director | Dec 16, 2016 | Option Exercise | $10.41 | 25,000 | 260,250 | 73,721 | Dec 16, 2016, 07:29 PM |
| FELDBAUM CARL B | Director | Dec 16, 2016 | Sale | $17.03 | 25,000 | 425,750 | 48,721 | Dec 16, 2016, 07:29 PM |
| Garber Alan M | Director | Dec 09, 2016 | Option Exercise | $10.53 | 10,000 | 105,300 | 69,161 | Dec 09, 2016, 08:02 PM |
| Garber Alan M | Director | Dec 09, 2016 | Sale | $16.90 | 7,832 | 132,361 | 61,329 | Dec 09, 2016, 08:02 PM |
| SCANGOS GEORGE A | Director | Dec 07, 2016 | Option Exercise | $8.99 | 356 | 3,200 | 1,463,824 | Dec 07, 2016, 07:03 PM |
| SCANGOS GEORGE A | Director | Dec 05, 2016 | Option Exercise | $8.99 | 357,976 | 3,218,204 | 1,668,186 | Dec 07, 2016, 07:03 PM |
| SCANGOS GEORGE A | Director | Dec 07, 2016 | Sale | $17.90 | 176 | 3,150 | 1,463,648 | Dec 07, 2016, 07:03 PM |
| SCANGOS GEORGE A | Director | Dec 05, 2016 | Sale | $17.81 | 204,718 | 3,646,027 | 1,463,468 | Dec 07, 2016, 07:03 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 01, 2016 | Option Exercise | $5.27 | 70,000 | 368,800 | 143,600 | Dec 02, 2016, 07:14 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Dec 01, 2016 | Sale | $16.66 | 70,000 | 1,166,200 | 73,600 | Dec 02, 2016, 07:14 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Dec 01, 2016 | Option Exercise | $8.99 | 22,000 | 197,780 | 180,053 | Dec 02, 2016, 07:13 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Dec 01, 2016 | Sale | $16.73 | 22,000 | 368,060 | 158,053 | Dec 02, 2016, 07:13 PM |
| Senner Christopher J. | EVP and CFO | Jul 15, 2016 | Option Exercise | $8.44 | 46,751 | 394,578 | 105,976 | Nov 23, 2016, 04:16 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 09, 2016 | Option Exercise | $8.99 | 200,000 | 1,798,000 | 260,000 | Nov 14, 2016, 07:37 PM |
| MORRISSEY MICHAEL | President and CEO | Nov 09, 2016 | Sale | $15.00 | 200,000 | 3,000,000 | 60,000 | Nov 14, 2016, 07:37 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Nov 09, 2016 | Option Exercise | $8.99 | 22,000 | 197,780 | 180,053 | Nov 14, 2016, 07:36 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Nov 09, 2016 | Sale | $15.00 | 22,000 | 330,000 | 158,053 | Nov 14, 2016, 07:36 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 09, 2016 | Option Exercise | $5.17 | 70,000 | 362,000 | 143,600 | Nov 14, 2016, 07:34 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Nov 09, 2016 | Sale | $13.15 | 70,000 | 920,500 | 73,600 | Nov 14, 2016, 07:34 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 31, 2016 | Option Exercise | $9.73 | 132,662 | 1,290,801 | 267,596 | Sep 02, 2016, 04:34 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 31, 2016 | Sale | $10.98 | 131,155 | 1,440,082 | 136,441 | Sep 02, 2016, 04:34 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 04, 2016 | Option Exercise | $9.73 | 42,338 | 411,949 | 174,354 | Aug 05, 2016, 07:29 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Aug 04, 2016 | Sale | $11.00 | 42,338 | 465,718 | 132,016 | Aug 05, 2016, 07:29 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Jun 01, 2016 | Option Exercise | $1.70 | 200,000 | 340,000 | 230,367 | Jun 02, 2016, 06:37 PM |
| WILLSEY LANCE | Director | May 11, 2016 | Buy | $4.95 | 20,000 | 99,000 | 568,273 | May 11, 2016, 05:23 PM |
| WILLSEY LANCE | Director | May 09, 2016 | Buy | $4.97 | 40,000 | 198,900 | 548,273 | May 11, 2016, 05:23 PM |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | Feb 11, 2016 | Option Exercise | $4.20 | 25,232 | 105,974 | 132,016 | Feb 16, 2016, 08:52 PM |
| Lamb Peter | EVP, Scientific Strategy & CSO | Feb 11, 2016 | Option Exercise | $4.20 | 25,454 | 106,907 | 57,350 | Feb 16, 2016, 08:51 PM |
| Hessekiel Jeffrey | EVP and General Counsel | Feb 11, 2016 | Option Exercise | $4.20 | 19,535 | 82,047 | 30,367 | Feb 16, 2016, 08:50 PM |
| Senner Christopher J. | EVP and CFO | Feb 11, 2016 | Option Exercise | $4.20 | 20,845 | 87,549 | 132,727 | Feb 16, 2016, 08:49 PM |
| MORRISSEY MICHAEL | President and CEO | Feb 11, 2016 | Option Exercise | $4.20 | 43,149 | 181,226 | 71,137 | Feb 16, 2016, 08:48 PM |
| WILLSEY LANCE | Director | Dec 11, 2015 | Buy | $4.78 | 50,000 | 239,000 | 494,975 | Dec 11, 2015, 07:43 PM |
| WILLSEY LANCE | Director | Dec 10, 2015 | Buy | $4.99 | 50,000 | 249,550 | 444,975 | Dec 11, 2015, 07:43 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 16, 2015 | Option Exercise | $5.63 | 51,549 | 290,221 | 88,022 | Oct 19, 2015, 05:08 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 16, 2015 | Sale | $5.80 | 51,549 | 298,984 | 36,473 | Oct 19, 2015, 05:08 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 13, 2015 | Option Exercise | $5.63 | 600 | 3,378 | 37,073 | Oct 14, 2015, 05:05 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 12, 2015 | Option Exercise | $5.63 | 300,276 | 1,690,554 | 336,749 | Oct 14, 2015, 05:05 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 13, 2015 | Sale | $5.80 | 600 | 3,480 | 36,473 | Oct 14, 2015, 05:05 PM |
| Lamb Peter | EVP, Discovery Research & CSO | Oct 12, 2015 | Sale | $5.84 | 300,276 | 1,753,312 | 36,473 | Oct 14, 2015, 05:05 PM |
| MARCHESI VINCENT T | Director | Sep 17, 2014 | Buy | $1.71 | 20,000 | 34,199 | 45,000 | Sep 19, 2014, 05:05 PM |
| WILLSEY LANCE | Director | Aug 29, 2013 | Buy | $5.15 | 10,000 | 51,454 | 333,700 | Aug 30, 2013, 06:44 PM |
| MARCHESI VINCENT T | Director | Dec 20, 2012 | Buy | $4.68 | 4,000 | 18,720 | 25,000 | Dec 20, 2012, 07:11 PM |
| MARCHESI VINCENT T | Director | Dec 19, 2012 | Buy | $4.67 | 1,500 | 7,005 | 21,000 | Dec 19, 2012, 07:49 PM |
| MARCHESI VINCENT T | Director | Dec 18, 2012 | Buy | $4.82 | 1,500 | 7,230 | 19,500 | Dec 19, 2012, 07:49 PM |
| MARCHESI VINCENT T | Director | Dec 17, 2012 | Buy | $4.70 | 3,000 | 14,093 | 18,000 | Dec 19, 2012, 07:49 PM |
| Schwab Gisela | EVP and Chief Medical Officer | Dec 10, 2012 | Buy | $4.39 | 25,000 | 109,750 | 56,874 | Dec 10, 2012, 08:25 PM |
| MARCHESI VINCENT T | Director | Jun 14, 2012 | Sale | $5.13 | 7,000 | 35,911 | 21,900 | Jun 15, 2012, 05:03 PM |
| RIVERA LUPE M | EVP, Operations | Dec 17, 2010 | Option Exercise | $5.45 | 29,427 | 160,317 | 25,000 | Dec 17, 2010, 08:52 PM |
| RIVERA LUPE M | EVP, Operations | Dec 17, 2010 | Sale | $8.50 | 29,427 | 250,130 | 0 | Dec 17, 2010, 08:52 PM |
| RIVERA LUPE M | EVP, Operations | Dec 15, 2010 | Option Exercise | $5.63 | 50,000 | 281,500 | 25,000 | Dec 16, 2010, 09:09 PM |
| RIVERA LUPE M | EVP, Operations | Dec 14, 2010 | Option Exercise | $5.63 | 25,000 | 140,750 | 11,750 | Dec 16, 2010, 09:09 PM |
| RIVERA LUPE M | EVP, Operations | Dec 15, 2010 | Sale | $7.75 | 50,000 | 387,500 | 0 | Dec 16, 2010, 09:09 PM |
| RIVERA LUPE M | EVP, Operations | Dec 14, 2010 | Sale | $7.00 | 25,000 | 175,000 | 0 | Dec 16, 2010, 09:09 PM |
| Schwab Gisela | EVP & Chief Medical Officer | Dec 09, 2010 | Sale | $6.50 | 4,112 | 26,728 | 7,322 | Dec 10, 2010, 07:54 PM |
| WILLSEY LANCE | Director | Sep 07, 2010 | Buy | $3.66 | 21,078 | 77,171 | 323,700 | Sep 08, 2010, 04:53 PM |
| WILLSEY LANCE | Director | Sep 03, 2010 | Buy | $3.52 | 15,122 | 53,299 | 302,622 | Sep 08, 2010, 04:53 PM |
| WILLSEY LANCE | Director | Aug 30, 2010 | Buy | $3.18 | 71,300 | 226,515 | 287,500 | Sep 01, 2010, 07:37 PM |
| WILLSEY LANCE | Director | Aug 27, 2010 | Buy | $3.26 | 28,700 | 93,539 | 216,200 | Aug 31, 2010, 07:55 PM |
| KARBE FRANK | EVP & CFO | Aug 24, 2010 | Buy | $2.98 | 16,500 | 49,165 | 60,110 | Aug 25, 2010, 08:51 PM |
| PAPADOPOULOS STELIOS | Director | Aug 24, 2010 | Buy | $3.05 | 200,000 | 610,197 | 1,143,956 | Aug 25, 2010, 08:48 PM |
| WILLSEY LANCE | Director | Aug 16, 2010 | Buy | $2.90 | 53,600 | 155,350 | 187,500 | Aug 17, 2010, 08:55 PM |
| WILLSEY LANCE | Director | Aug 13, 2010 | Buy | $2.97 | 46,400 | 137,690 | 133,900 | Aug 17, 2010, 08:55 PM |
| MORRISSEY MICHAEL | President & CEO | Aug 13, 2010 | Buy | $2.94 | 30,000 | 88,344 | 72,500 | Aug 17, 2010, 08:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Garber Alan M | Director | 03/21/2024 | 459,719 |
| Garber Alan M | Director | 03/21/2024 | 461,112 |
| Haley Patrick J. | EVP, Commercial | 02/23/2024 | 1,008,579 |
| JOHNSON DAVID EDWARD | Director | 02/21/2024 | 3,932,734 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/15/2024 | 216,746 |
| MORRISSEY MICHAEL | President and CEO | 01/11/2024 | 1,456,571 |
| Senner Christopher J. | EVP and CFO | 01/11/2024 | 499,765 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 01/11/2024 | 298,574 |
| Haley Patrick J. | EVP, Commercial | 01/11/2024 | 311,193 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 01/11/2024 | 265,313 |
| Haley Patrick J. | EVP, Commercial | 12/14/2023 | 814,500 |
| Haley Patrick J. | EVP, Commercial | 12/12/2023 | 318,353 |
| Haley Patrick J. | EVP, Commercial | 12/14/2023 | 1,167,500 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 12/13/2023 | 575,250 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 12/04/2023 | 551,500 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 11/30/2023 | 550,250 |
| JOHNSON DAVID EDWARD | Director | 11/27/2023 | 2,602,039 |
| JOHNSON DAVID EDWARD | Director | 11/27/2023 | 2,602,039 |
| MORRISSEY MICHAEL | President and CEO | 09/06/2023 | 1,037,960 |
| Senner Christopher J. | EVP and CFO | 09/06/2023 | 381,864 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 09/06/2023 | 279,711 |
| Haley Patrick J. | EVP, Commercial | 09/06/2023 | 319,664 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 09/06/2023 | 319,664 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 08/30/2023 | 103,362 |
| MORRISSEY MICHAEL | President and CEO | 08/28/2023 | 6,737,818 |
| MORRISSEY MICHAEL | President and CEO | 08/28/2023 | 5,511,600 |
| MORRISSEY MICHAEL | President and CEO | 08/15/2023 | 501,269 |
| Senner Christopher J. | EVP and CFO | 08/15/2023 | 173,672 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 08/15/2023 | 154,377 |
| Haley Patrick J. | EVP, Commercial | 08/15/2023 | 154,377 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 08/15/2023 | 135,083 |
| Senner Christopher J. | EVP and CFO | 08/04/2023 | 884,400 |
| Senner Christopher J. | EVP and CFO | 08/03/2023 | 884,400 |
| Senner Christopher J. | EVP and CFO | 08/04/2023 | 1,240,800 |
| Senner Christopher J. | EVP and CFO | 08/03/2023 | 1,230,600 |
| Haley Patrick J. | EVP, Commercial | 08/03/2023 | 631,531 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 08/01/2023 | 821,165 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 08/01/2023 | 1,093,587 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 05/15/2023 | 229,527 |
| Senner Christopher J. | EVP and CFO | 05/15/2023 | 353,794 |
| MORRISSEY MICHAEL | President and CEO | 05/15/2023 | 642,875 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 05/15/2023 | 201,160 |
| Haley Patrick J. | EVP, Commercial | 05/15/2023 | 346,487 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 04/05/2023 | 205,328 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 04/05/2023 | 778,989 |
| WYSZOMIERSKI JACK L | Director | 03/10/2023 | 252,000 |
| WYSZOMIERSKI JACK L | Director | 03/10/2023 | 254,133 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 03/01/2023 | 410,656 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 03/01/2023 | 1,333,742 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/28/2023 | 1,215,903 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/27/2023 | 147 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/27/2023 | 175 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/28/2023 | 1,443,575 |
| Garber Alan M | Director | 02/21/2023 | 252,000 |
| Garber Alan M | Director | 02/21/2023 | 699,600 |
| MORRISSEY MICHAEL | President and CEO | 02/15/2023 | 208,318 |
| Haley Patrick J. | EVP, Commercial | 02/15/2023 | 28,132 |
| Senner Christopher J. | EVP and CFO | 02/15/2023 | 95,426 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 02/15/2023 | 34,876 |
| Aftab Dana | CSO/EVP Disc & Trans Research | 02/15/2023 | 27,644 |
| Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | 02/15/2023 | 312,766 |
| FELDBAUM CARL B | Director | 02/09/2023 | 252,000 |
| FELDBAUM CARL B | Director | 02/09/2023 | 711,200 |
| Haley Patrick J. | EVP, Commercial | 02/06/2023 | 105,000 |
| Haley Patrick J. | EVP, Commercial | 02/06/2023 | 434,250 |
| MORRISSEY MICHAEL | President and CEO | 01/24/2023 | 1,076,424 |
| MORRISSEY MICHAEL | President and CEO | 01/24/2023 | 420,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/15/2022 | 84,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/15/2022 | 317,600 |
| POSTE GEORGE | Director | 11/29/2022 | 252,000 |
| POSTE GEORGE | Director | 11/29/2022 | 667,200 |
| Haley Patrick J. | EVP, Commercial | 11/15/2022 | 119,928 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 11/15/2022 | 119,928 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 05/16/2022 | 361,260 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 05/17/2021 | 457,020 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2022 | 119,928 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2022 | 389,410 |
| Senner Christopher J. | EVP and CFO | 11/15/2022 | 134,917 |
| Haley Patrick J. | EVP, Commercial | 09/12/2022 | 248,400 |
| Haley Patrick J. | EVP, Commercial | 09/12/2022 | 717,600 |
| Senner Christopher J. | EVP and CFO | 08/11/2022 | 2,939,632 |
| Senner Christopher J. | EVP and CFO | 08/11/2022 | 1,397,250 |
| MORRISSEY MICHAEL | President and CEO | 08/03/2022 | 500,803 |
| Senner Christopher J. | EVP and CFO | 08/03/2022 | 173,510 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 08/03/2022 | 154,234 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 08/03/2022 | 154,234 |
| Haley Patrick J. | EVP, Commercial | 08/03/2022 | 154,234 |
| Haley Patrick J. | EVP, Commercial | 05/27/2022 | 342,567 |
| Haley Patrick J. | EVP, Commercial | 05/15/2022 | 235,398 |
| Senner Christopher J. | EVP and CFO | 05/15/2022 | 169,556 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 05/15/2022 | 122,950 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 05/15/2022 | 107,408 |
| WILLSEY LANCE | Director | 05/12/2022 | 125,200 |
| WILLSEY LANCE | Director | 05/12/2022 | 786,000 |
| WYSZOMIERSKI JACK L | Director | 04/04/2022 | 125,200 |
| WYSZOMIERSKI JACK L | Director | 04/04/2022 | 154,008 |
| Haley Patrick J. | EVP, Commercial | 04/01/2022 | 62,100 |
| Haley Patrick J. | EVP, Commercial | 03/31/2022 | 62,100 |
| Haley Patrick J. | EVP, Commercial | 04/01/2022 | 230,000 |
| Haley Patrick J. | EVP, Commercial | 03/31/2022 | 224,300 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 03/29/2022 | 292,226 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | 03/28/2022 | 103,774 |
| Garber Alan M | Director | 03/01/2022 | 125,200 |
| Garber Alan M | Director | 03/01/2022 | 447,321 |
| Hessekiel Jeffrey | EVP and General Counsel | 02/24/2022 | 360,000 |
| Haley Patrick J. | EVP, Commercial | 02/25/2022 | 610,078 |
| PAPADOPOULOS STELIOS | Director | 02/22/2022 | 1,653,113 |
| FELDBAUM CARL B | Director | 02/22/2022 | 62,600 |
| FELDBAUM CARL B | Director | 02/22/2022 | 389,800 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/15/2022 | 375,090 |
| Hessekiel Jeffrey | EVP and General Counsel | 02/15/2022 | 227,281 |
| MORRISSEY MICHAEL | President and CEO | 02/15/2022 | 1,211,083 |
| Senner Christopher J. | EVP and CFO | 02/15/2022 | 340,699 |
| Haley Patrick J. | EVP, Commercial | 02/15/2022 | 288,647 |
| Haley Patrick J. | EVP, Commercial | 02/03/2022 | 114,000 |
| Haley Patrick J. | EVP, Commercial | 02/03/2022 | 1,074,600 |
| Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | 01/04/2022 | 146,017 |
| MORRISSEY MICHAEL | President and CEO | 12/15/2021 | 208,012 |
| Haley Patrick J. | EVP, Commercial | 12/15/2021 | 26,452 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/15/2021 | 78,982 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/15/2021 | 294,975 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/15/2021 | 828,400 |
| Senner Christopher J. | EVP and CFO | 12/15/2021 | 87,227 |
| Hessekiel Jeffrey | EVP and General Counsel | 12/15/2021 | 44,557 |
| Haley Patrick J. | EVP, Commercial | 11/24/2021 | 297,321 |
| FELDBAUM CARL B | Director | 11/19/2021 | 62,600 |
| FELDBAUM CARL B | Director | 11/19/2021 | 352,400 |
| Haley Patrick J. | EVP, Commercial | 11/15/2021 | 895,769 |
| Senner Christopher J. | EVP and CFO | 11/15/2021 | 1,044,605 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2021 | 988,459 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2021 | 3,507,418 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2021 | 1,125,150 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2021 | 294,975 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2021 | 859,275 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/01/2021 | 112,728 |
| MORRISSEY MICHAEL | President and CEO | 10/22/2021 | 527,854 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 10/15/2021 | 294,975 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 10/15/2021 | 1,041,200 |
| Hessekiel Jeffrey | EVP and General Counsel | 10/15/2021 | 283,684 |
| Senner Christopher J. | EVP and CFO | 09/30/2021 | 176,861 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/30/2021 | 156,644 |
| Haley Patrick J. | EVP, Commercial | 09/30/2021 | 111,732 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 09/30/2021 | 148,062 |
| Senner Christopher J. | EVP and CFO | 09/21/2021 | 1,119,309 |
| Senner Christopher J. | EVP and CFO | 09/21/2021 | 329,400 |
| Haley Patrick J. | EVP, Commercial | 09/16/2021 | 42,500 |
| Haley Patrick J. | EVP, Commercial | 09/16/2021 | 509,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 09/15/2021 | 294,975 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 09/15/2021 | 971,850 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 08/16/2021 | 104,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 08/16/2021 | 1,014,200 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 07/26/2021 | 168,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 07/21/2021 | 147,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 07/15/2021 | 114,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 07/15/2021 | 1,048,200 |
| COHEN CHARLES | Director | 07/06/2021 | 377,200 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/17/2021 | 114,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/17/2021 | 1,330,800 |
| Freire Maria C | Director | 05/11/2021 | 206,958 |
| POSTE GEORGE | Director | 05/14/2021 | 1,018,826 |
| MORRISSEY MICHAEL | President and CEO | 05/12/2021 | 761,794 |
| MORRISSEY MICHAEL | President and CEO | 05/12/2021 | 210,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 05/13/2021 | 190,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 05/13/2021 | 2,538,000 |
| PAPADOPOULOS STELIOS | Director | 05/11/2021 | 512,400 |
| PAPADOPOULOS STELIOS | Director | 05/11/2021 | 518,794 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/26/2021 | 85,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/26/2021 | 1,250,000 |
| Haley Patrick J. | EVP, Commercial | 04/26/2021 | 191,855 |
| Hessekiel Jeffrey | EVP and General Counsel | 04/26/2021 | 450,540 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 04/01/2021 | 102,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 04/01/2021 | 1,377,600 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/01/2021 | 85,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/01/2021 | 1,150,000 |
| WYSZOMIERSKI JACK L | Director | 03/29/2021 | 135,200 |
| WYSZOMIERSKI JACK L | Director | 03/29/2021 | 140,821 |
| Garber Alan M | Director | 03/15/2021 | 135,200 |
| Garber Alan M | Director | 03/15/2021 | 944,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 03/01/2021 | 110,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 03/01/2021 | 1,437,150 |
| COHEN CHARLES | Director | 02/24/2021 | 135,200 |
| COHEN CHARLES | Director | 02/24/2021 | 907,600 |
| POSTE GEORGE | Director | 02/22/2021 | 135,200 |
| MARCHESI VINCENT T | Director | 02/22/2021 | 537,122 |
| WILLSEY LANCE | Director | 02/23/2021 | 135,200 |
| WILLSEY LANCE | Director | 02/16/2021 | 1,095,000 |
| WILLSEY LANCE | Director | 02/23/2021 | 877,136 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/18/2021 | 85,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/17/2021 | 85,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/18/2021 | 1,117,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/17/2021 | 1,125,000 |
| Haley Patrick J. | EVP, Commercial | 02/15/2021 | 30,674 |
| Haley Patrick J. | EVP, Commercial | 02/12/2021 | 970,650 |
| Senner Christopher J. | EVP and CFO | 02/15/2021 | 89,941 |
| Hessekiel Jeffrey | EVP and General Counsel | 02/15/2021 | 36,918 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/15/2021 | 62,619 |
| MORRISSEY MICHAEL | President and CEO | 02/15/2021 | 214,477 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/15/2021 | 81,461 |
| FELDBAUM CARL B | Director | 02/16/2021 | 67,600 |
| FELDBAUM CARL B | Director | 02/16/2021 | 439,200 |
| MORRISSEY MICHAEL | President and CEO | 02/03/2021 | 1,470,686 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/03/2021 | 451,132 |
| Hessekiel Jeffrey | EVP and General Counsel | 02/03/2021 | 346,634 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/03/2021 | 337,994 |
| Haley Patrick J. | EVP, Commercial | 02/03/2021 | 254,184 |
| Senner Christopher J. | EVP and CFO | 02/03/2021 | 410,727 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/01/2021 | 110,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/01/2021 | 1,435,200 |
| Senner Christopher J. | EVP and CFO | 01/12/2021 | 109,800 |
| Senner Christopher J. | EVP and CFO | 01/12/2021 | 750,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 01/04/2021 | 110,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 01/04/2021 | 1,320,800 |
| Hessekiel Jeffrey | EVP and General Counsel | 01/04/2021 | 256,100 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/18/2020 | 110,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/18/2020 | 1,300,650 |
| WILLSEY LANCE | Director | 12/04/2020 | 617,746 |
| MARCHESI VINCENT T | Director | 11/24/2020 | 232,823 |
| MARCHESI VINCENT T | Director | 11/24/2020 | 740,074 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2020 | 503,073 |
| Haley Patrick J. | EVP, Commercial | 11/15/2020 | 210,591 |
| Senner Christopher J. | EVP and CFO | 11/15/2020 | 274,116 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2020 | 228,030 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2020 | 206,862 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2020 | 218,100 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/15/2020 | 301,452 |
| WYSZOMIERSKI JACK L | Director | 11/10/2020 | 363,185 |
| WYSZOMIERSKI JACK L | Director | 11/10/2020 | 700,740 |
| MORRISSEY MICHAEL | President and CEO | 10/22/2020 | 3,859,706 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 10/22/2020 | 1,203,571 |
| Haley Patrick J. | EVP, Commercial | 10/22/2020 | 962,769 |
| Hessekiel Jeffrey | EVP and General Counsel | 10/22/2020 | 1,018,508 |
| Senner Christopher J. | EVP and CFO | 10/22/2020 | 1,022,387 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 10/22/2020 | 1,155,349 |
| Hessekiel Jeffrey | EVP and General Counsel | 10/21/2020 | 288,924 |
| Hessekiel Jeffrey | EVP and General Counsel | 10/21/2020 | 872,337 |
| Senner Christopher J. | EVP and CFO | 10/08/2020 | 36,600 |
| Senner Christopher J. | EVP and CFO | 10/08/2020 | 250,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/22/2020 | 74,576 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/22/2020 | 268,144 |
| Haley Patrick J. | EVP, Commercial | 09/21/2020 | 27,238 |
| Haley Patrick J. | EVP, Commercial | 09/21/2020 | 122,101 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/16/2020 | 145,400 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/16/2020 | 522,200 |
| Senner Christopher J. | EVP and CFO | 09/15/2020 | 73,200 |
| Senner Christopher J. | EVP and CFO | 09/15/2020 | 500,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/08/2020 | 3,327,393 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/08/2020 | 1,293,315 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 09/02/2020 | 50,130 |
| Haley Patrick J. | EVP, Commercial | 09/02/2020 | 24,083 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/02/2020 | 28,291 |
| Senner Christopher J. | EVP and CFO | 09/02/2020 | 55,374 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 09/02/2020 | 54,317 |
| MORRISSEY MICHAEL | President and CEO | 09/02/2020 | 132,026 |
| COHEN CHARLES | Director | 09/01/2020 | 671,605 |
| POSTE GEORGE | Director | 08/14/2020 | 172,633 |
| MORRISSEY MICHAEL | President and CEO | 07/20/2020 | 1,641,907 |
| MORRISSEY MICHAEL | President and CEO | 07/20/2020 | 621,000 |
| Haley Patrick J. | EVP, Commercial | 07/20/2020 | 79,909 |
| MORRISSEY MICHAEL | President and CEO | 07/10/2020 | 1,607,159 |
| MORRISSEY MICHAEL | President and CEO | 07/10/2020 | 621,000 |
| MORRISSEY MICHAEL | President and CEO | 06/19/2020 | 1,567,130 |
| MORRISSEY MICHAEL | President and CEO | 06/19/2020 | 621,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/08/2020 | 143,260 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/08/2020 | 586,560 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 06/04/2020 | 170,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 06/04/2020 | 2,296,000 |
| MORRISSEY MICHAEL | President and CEO | 05/29/2020 | 1,595,030 |
| MORRISSEY MICHAEL | President and CEO | 05/29/2020 | 621,000 |
| MARCHESI VINCENT T | Director | 05/21/2020 | 232,800 |
| MARCHESI VINCENT T | Director | 05/21/2020 | 985,600 |
| Garber Alan M | Director | 05/22/2020 | 881,831 |
| Haley Patrick J. | EVP, Commercial | 05/20/2020 | 78,743 |
| WILLSEY LANCE | Director | 05/18/2020 | 137,400 |
| WILLSEY LANCE | Director | 05/18/2020 | 787,800 |
| SCANGOS GEORGE A | Director | 05/18/2020 | 1,947,000 |
| MORRISSEY MICHAEL | President and CEO | 05/15/2020 | 1,650,314 |
| MORRISSEY MICHAEL | President and CEO | 05/15/2020 | 621,000 |
| SCANGOS GEORGE A | Director | 05/15/2020 | 263,613 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/13/2020 | 368,104 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/13/2020 | 42,500 |
| WILLSEY LANCE | Director | 05/14/2020 | 88,800 |
| WILLSEY LANCE | Director | 05/14/2020 | 378,900 |
| PAPADOPOULOS STELIOS | Director | 05/13/2020 | 703,004 |
| MARCHESI VINCENT T | Director | 05/11/2020 | 137,400 |
| MARCHESI VINCENT T | Director | 05/11/2020 | 789,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/07/2020 | 57,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/11/2020 | 72,211 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/08/2020 | 47,500 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/11/2020 | 1,029,583 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/08/2020 | 651,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/07/2020 | 768,300 |
| Senner Christopher J. | EVP and CFO | 05/08/2020 | 287,614 |
| Senner Christopher J. | EVP and CFO | 05/07/2020 | 78,386 |
| Senner Christopher J. | EVP and CFO | 05/08/2020 | 2,028,227 |
| Senner Christopher J. | EVP and CFO | 05/07/2020 | 552,559 |
| PAPADOPOULOS STELIOS | Director | 05/08/2020 | 226,200 |
| PAPADOPOULOS STELIOS | Director | 05/08/2020 | 1,162,800 |
| Haley Patrick J. | EVP, Commercial | 05/08/2020 | 37,620 |
| Haley Patrick J. | EVP, Commercial | 05/08/2020 | 552,971 |
| FELDBAUM CARL B | Director | 05/07/2020 | 134,798 |
| FELDBAUM CARL B | Director | 05/07/2020 | 789,281 |
| POSTE GEORGE | Director | 05/07/2020 | 174,600 |
| POSTE GEORGE | Director | 05/07/2020 | 768,300 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 05/07/2020 | 275,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 05/07/2020 | 1,277,000 |
| MORRISSEY MICHAEL | President and CEO | 05/06/2020 | 4,163,451 |
| MORRISSEY MICHAEL | President and CEO | 05/06/2020 | 484,983 |
| MORRISSEY MICHAEL | President and CEO | 04/27/2020 | 4,336,366 |
| MORRISSEY MICHAEL | President and CEO | 04/27/2020 | 484,500 |
| MORRISSEY MICHAEL | President and CEO | 04/23/2020 | 4,123,213 |
| MORRISSEY MICHAEL | President and CEO | 04/23/2020 | 1,377,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/23/2020 | 170,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/23/2020 | 2,600,000 |
| SCANGOS GEORGE A | Director | 04/24/2020 | 393,600 |
| SCANGOS GEORGE A | Director | 04/23/2020 | 2,598,635 |
| Haley Patrick J. | EVP, Commercial | 04/23/2020 | 8,500 |
| Haley Patrick J. | EVP, Commercial | 04/23/2020 | 130,000 |
| MORRISSEY MICHAEL | President and CEO | 04/21/2020 | 3,418,776 |
| MORRISSEY MICHAEL | President and CEO | 04/20/2020 | 3,605,877 |
| MORRISSEY MICHAEL | President and CEO | 04/21/2020 | 1,212,200 |
| MORRISSEY MICHAEL | President and CEO | 04/20/2020 | 1,322,400 |
| SCANGOS GEORGE A | Director | 04/21/2020 | 145,232 |
| SCANGOS GEORGE A | Director | 04/20/2020 | 1,194,637 |
| SCANGOS GEORGE A | Director | 04/22/2020 | 105,210 |
| Haley Patrick J. | EVP, Commercial | 04/20/2020 | 8,500 |
| Haley Patrick J. | EVP, Commercial | 04/20/2020 | 120,000 |
| SCANGOS GEORGE A | Director | 04/15/2020 | 457,750 |
| SCANGOS GEORGE A | Director | 04/08/2020 | 129,643 |
| SCANGOS GEORGE A | Director | 04/07/2020 | 299,939 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 04/06/2020 | 275,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 04/06/2020 | 863,000 |
| WYSZOMIERSKI JACK L | Director | 04/03/2020 | 226,200 |
| WYSZOMIERSKI JACK L | Director | 04/03/2020 | 229,461 |
| SCANGOS GEORGE A | Director | 03/31/2020 | 27,090 |
| Haley Patrick J. | EVP, Commercial | 03/20/2020 | 66,368 |
| MORRISSEY MICHAEL | President and CEO | 03/04/2020 | 654,063 |
| MORRISSEY MICHAEL | President and CEO | 03/04/2020 | 275,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 03/04/2020 | 170,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 03/04/2020 | 1,940,000 |
| FELDBAUM CARL B | Director | 03/03/2020 | 213,720 |
| FELDBAUM CARL B | Director | 03/03/2020 | 716,013 |
| COHEN CHARLES | Director | 02/28/2020 | 226,200 |
| MORRISSEY MICHAEL | President and CEO | 02/26/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 02/26/2020 | 472,850 |
| SCANGOS GEORGE A | Director | 02/18/2020 | 1,036,500 |
| Haley Patrick J. | EVP, Commercial | 02/19/2020 | 110,000 |
| MORRISSEY MICHAEL | President and CEO | 02/19/2020 | 543,750 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/19/2020 | 220,400 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/19/2020 | 860,000 |
| MORRISSEY MICHAEL | President and CEO | 02/13/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 02/13/2020 | 502,750 |
| Garber Alan M | Director | 02/14/2020 | 262,750 |
| SCANGOS GEORGE A | Director | 02/12/2020 | 420,420 |
| SCANGOS GEORGE A | Director | 02/11/2020 | 80,560 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/07/2020 | 275,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/07/2020 | 918,500 |
| MORRISSEY MICHAEL | President and CEO | 01/29/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 01/29/2020 | 446,750 |
| MORRISSEY MICHAEL | President and CEO | 01/23/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 01/23/2020 | 485,250 |
| SCANGOS GEORGE A | Director | 01/22/2020 | 493,750 |
| MARCHESI VINCENT T | Director | 01/15/2020 | 1,234,277 |
| MORRISSEY MICHAEL | President and CEO | 01/16/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 01/16/2020 | 508,250 |
| SCANGOS GEORGE A | Director | 01/15/2020 | 509,750 |
| MORRISSEY MICHAEL | President and CEO | 01/08/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 01/08/2020 | 471,250 |
| Garber Alan M | Director | 01/07/2020 | 468,884 |
| Garber Alan M | Director | 01/07/2020 | 1,566,078 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 01/07/2020 | 275,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 01/07/2020 | 898,000 |
| MORRISSEY MICHAEL | President and CEO | 01/02/2020 | 137,750 |
| MORRISSEY MICHAEL | President and CEO | 01/02/2020 | 437,250 |
| SCANGOS GEORGE A | Director | 12/27/2019 | 456,250 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 12/04/2019 | 71,157 |
| Hessekiel Jeffrey | EVP and General Counsel | 12/04/2019 | 41,701 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/04/2019 | 68,418 |
| Haley Patrick J. | Sr. Vice President, Commercial | 12/04/2019 | 35,464 |
| Senner Christopher J. | EVP and CFO | 12/04/2019 | 72,270 |
| MORRISSEY MICHAEL | President and CEO | 12/04/2019 | 172,954 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 12/03/2019 | 275,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 12/03/2019 | 811,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2019 | 143,439 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/15/2019 | 202,545 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2019 | 151,909 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2019 | 304,246 |
| Senner Christopher J. | EVP and CFO | 11/15/2019 | 178,622 |
| Haley Patrick J. | Sr. Vice President, Commercial | 11/15/2019 | 150,357 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/04/2019 | 275,500 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/04/2019 | 799,500 |
| Haley Patrick J. | Sr. Vice President, Commercial | 10/10/2019 | 4,930 |
| MORRISSEY MICHAEL | President and CEO | 10/02/2019 | 254,237 |
| MORRISSEY MICHAEL | President and CEO | 10/02/2019 | 465,588 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 10/01/2019 | 165,300 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 10/01/2019 | 536,100 |
| MORRISSEY MICHAEL | President and CEO | 09/18/2019 | 359,000 |
| MORRISSEY MICHAEL | President and CEO | 09/18/2019 | 714,758 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/12/2019 | 28,640 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 09/12/2019 | 49,710 |
| MORRISSEY MICHAEL | President and CEO | 09/12/2019 | 125,691 |
| Haley Patrick J. | Sr. Vice President, Commercial | 09/12/2019 | 25,770 |
| Senner Christopher J. | EVP and CFO | 09/12/2019 | 52,715 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 09/12/2019 | 49,633 |
| Haley Patrick J. | Sr. Vice President, Commercial | 09/10/2019 | 18,840 |
| Hessekiel Jeffrey | EVP and General Counsel | 08/16/2019 | 127,500 |
| Hessekiel Jeffrey | EVP and General Counsel | 08/16/2019 | 1,582,500 |
| POSTE GEORGE | Director | 08/16/2019 | 114,500 |
| POSTE GEORGE | Director | 08/16/2019 | 512,500 |
| MORRISSEY MICHAEL | President and CEO | 08/14/2019 | 359,000 |
| MORRISSEY MICHAEL | President and CEO | 08/14/2019 | 704,654 |
| Haley Patrick J. | Sr. Vice President, Commercial | 08/12/2019 | 20,390 |
| POSTE GEORGE | Director | 08/09/2019 | 111,700 |
| POSTE GEORGE | Director | 08/09/2019 | 412,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 08/06/2019 | 42,500 |
| Haley Patrick J. | Sr. Vice President, Commercial | 08/06/2019 | 500,500 |
| MORRISSEY MICHAEL | President and CEO | 08/02/2019 | 359,000 |
| MORRISSEY MICHAEL | President and CEO | 08/02/2019 | 709,560 |
| SCANGOS GEORGE A | Director | 08/01/2019 | 823,737 |
| MORRISSEY MICHAEL | President and CEO | 07/17/2019 | 359,000 |
| MORRISSEY MICHAEL | President and CEO | 07/17/2019 | 741,988 |
| Haley Patrick J. | Sr. Vice President, Commercial | 07/10/2019 | 20,960 |
| SCANGOS GEORGE A | Director | 07/01/2019 | 863,200 |
| MORRISSEY MICHAEL | President and CEO | 07/03/2019 | 359,000 |
| MORRISSEY MICHAEL | President and CEO | 07/03/2019 | 730,183 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/18/2019 | 263,711 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/17/2019 | 538,259 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/19/2019 | 95,896 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/17/2019 | 2,410,307 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/18/2019 | 2,067,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/13/2019 | 153,434 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 06/13/2019 | 552,748 |
| Haley Patrick J. | Sr. Vice President, Commercial | 06/10/2019 | 20,230 |
| SCANGOS GEORGE A | Director | 06/03/2019 | 490,250 |
| SCANGOS GEORGE A | Director | 06/04/2019 | 300,000 |
| MORRISSEY MICHAEL | President and CEO | 05/29/2019 | 104,763 |
| SCANGOS GEORGE A | Director | 05/21/2019 | 68,550 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/10/2019 | 19,580 |
| MORRISSEY MICHAEL | President and CEO | 05/08/2019 | 233,520 |
| MORRISSEY MICHAEL | President and CEO | 05/08/2019 | 846,300 |
| WILLSEY LANCE | Director | 05/08/2019 | 1,018,000 |
| Senner Christopher J. | EVP and CFO | 05/03/2019 | 750,603 |
| SCANGOS GEORGE A | Director | 05/02/2019 | 300,000 |
| SCANGOS GEORGE A | Director | 05/01/2019 | 493,750 |
| MORRISSEY MICHAEL | President and CEO | 04/24/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 04/24/2019 | 830,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 04/10/2019 | 24,040 |
| MORRISSEY MICHAEL | President and CEO | 04/10/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 04/10/2019 | 962,400 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/03/2019 | 453,123 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 04/03/2019 | 1,577,725 |
| WYSZOMIERSKI JACK L | Director | 04/01/2019 | 115,350 |
| WYSZOMIERSKI JACK L | Director | 04/01/2019 | 187,493 |
| SCANGOS GEORGE A | Director | 04/03/2019 | 125,150 |
| SCANGOS GEORGE A | Director | 04/01/2019 | 960,800 |
| Hessekiel Jeffrey | EVP and General Counsel | 04/01/2019 | 34,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 04/01/2019 | 480,600 |
| Garber Alan M | Director | 04/01/2019 | 157,350 |
| Garber Alan M | Director | 04/01/2019 | 719,550 |
| MORRISSEY MICHAEL | President and CEO | 03/27/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 03/27/2019 | 935,600 |
| POSTE GEORGE | Director | 03/29/2019 | 68,550 |
| POSTE GEORGE | Director | 03/29/2019 | 92,215 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 03/25/2019 | 718,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 03/25/2019 | 2,314,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/26/2019 | 13,986 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/26/2019 | 63,369 |
| SCANGOS GEORGE A | Director | 03/14/2019 | 125,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/14/2019 | 3,520 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/14/2019 | 50,000 |
| MORRISSEY MICHAEL | President and CEO | 03/13/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 03/13/2019 | 985,485 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/11/2019 | 22,182 |
| MORRISSEY MICHAEL | President and CEO | 02/27/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 02/27/2019 | 907,600 |
| SCANGOS GEORGE A | Director | 03/01/2019 | 906,400 |
| COHEN CHARLES | Director | 02/25/2019 | 115,350 |
| COHEN CHARLES | Director | 02/25/2019 | 116,911 |
| Haley Patrick J. | Sr. Vice President, Commercial | 02/25/2019 | 95,137 |
| PAPADOPOULOS STELIOS | Director | 02/21/2019 | 115,350 |
| PAPADOPOULOS STELIOS | Director | 02/21/2019 | 557,813 |
| WILLSEY LANCE | Director | 02/20/2019 | 115,350 |
| WILLSEY LANCE | Director | 02/20/2019 | 554,138 |
| MARCHESI VINCENT T | Director | 02/22/2019 | 204,150 |
| MARCHESI VINCENT T | Director | 02/22/2019 | 886,875 |
| COHEN CHARLES | Director | 02/15/2019 | 2,219,000 |
| COHEN CHARLES | Director | 02/14/2019 | 2,241,000 |
| COHEN CHARLES | Director | 02/19/2019 | 1,034,906 |
| MORRISSEY MICHAEL | President and CEO | 02/14/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 02/14/2019 | 895,654 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/15/2019 | 127,880 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/14/2019 | 556,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/15/2019 | 510,600 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 02/14/2019 | 2,166,000 |
| FELDBAUM CARL B | Director | 02/14/2019 | 251,275 |
| FELDBAUM CARL B | Director | 02/14/2019 | 1,112,515 |
| Haley Patrick J. | Sr. Vice President, Commercial | 02/11/2019 | 21,300 |
| SCANGOS GEORGE A | Director | 02/01/2019 | 941,200 |
| MORRISSEY MICHAEL | President and CEO | 01/30/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 01/30/2019 | 924,800 |
| MORRISSEY MICHAEL | President and CEO | 01/16/2019 | 222,400 |
| MORRISSEY MICHAEL | President and CEO | 01/16/2019 | 931,456 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/10/2019 | 3,520 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/10/2019 | 71,540 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/09/2019 | 9,079 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/08/2019 | 3,520 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/07/2019 | 16,119 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/08/2019 | 46,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/07/2019 | 119,620 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/09/2019 | 36,660 |
| Garber Alan M | Director | 01/08/2019 | 46,800 |
| Garber Alan M | Director | 01/08/2019 | 258,750 |
| MORRISSEY MICHAEL | President and CEO | 01/04/2019 | 168,929 |
| MORRISSEY MICHAEL | President and CEO | 01/03/2019 | 19,855 |
| MORRISSEY MICHAEL | President and CEO | 01/02/2019 | 33,616 |
| MORRISSEY MICHAEL | President and CEO | 01/04/2019 | 611,914 |
| MORRISSEY MICHAEL | President and CEO | 01/03/2019 | 71,420 |
| MORRISSEY MICHAEL | President and CEO | 01/02/2019 | 120,920 |
| SCANGOS GEORGE A | Director | 01/03/2019 | 1,920 |
| SCANGOS GEORGE A | Director | 01/02/2019 | 783,715 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/03/2019 | 14,080 |
| Haley Patrick J. | Sr. Vice President, Commercial | 01/03/2019 | 159,600 |
| SCANGOS GEORGE A | Director | 12/03/2018 | 846,400 |
| SCANGOS GEORGE A | Director | 11/30/2018 | 170,000 |
| SCANGOS GEORGE A | Director | 11/29/2018 | 130,000 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 12/03/2018 | 68,035 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 12/03/2018 | 283,749 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/30/2018 | 38,685 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/29/2018 | 21,773 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/28/2018 | 224,832 |
| Senner Christopher J. | EVP and CFO | 11/30/2018 | 173,183 |
| Senner Christopher J. | EVP and CFO | 11/15/2018 | 135,482 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/15/2018 | 205,474 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2018 | 302,810 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2018 | 110,500 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2018 | 430,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2018 | 160,523 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2018 | 101,419 |
| Haley Patrick J. | Sr. Vice President, Commercial | 11/15/2018 | 158,900 |
| Haley Patrick J. | Sr. Vice President, Commercial | 11/07/2018 | 346,400 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/01/2018 | 60,480 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 11/01/2018 | 169,920 |
| SCANGOS GEORGE A | Director | 11/01/2018 | 366,400 |
| MORRISSEY MICHAEL | President and CEO | 11/02/2018 | 188,995 |
| MORRISSEY MICHAEL | President and CEO | 11/02/2018 | 658,964 |
| SCANGOS GEORGE A | Director | 10/01/2018 | 446,500 |
| MORRISSEY MICHAEL | President and CEO | 10/01/2018 | 63,005 |
| MORRISSEY MICHAEL | President and CEO | 10/01/2018 | 222,768 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 10/01/2018 | 60,480 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | 10/01/2018 | 213,240 |
| SCANGOS GEORGE A | Director | 09/24/2018 | 421,250 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/04/2018 | 123,750 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/04/2018 | 416,925 |
| MORRISSEY MICHAEL | President and CEO | 08/20/2018 | 495,000 |
| MORRISSEY MICHAEL | President and CEO | 08/20/2018 | 1,604,216 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/17/2018 | 275,500 |
| MARCHESI VINCENT T | Director | 08/15/2018 | 135,200 |
| MARCHESI VINCENT T | Director | 08/15/2018 | 780,000 |
| SCANGOS GEORGE A | Director | 08/10/2018 | 525,332 |
| MORRISSEY MICHAEL | President and CEO | 08/07/2018 | 170,000 |
| MORRISSEY MICHAEL | President and CEO | 08/09/2018 | 58,254 |
| MORRISSEY MICHAEL | President and CEO | 08/08/2018 | 170,000 |
| MORRISSEY MICHAEL | President and CEO | 08/07/2018 | 2,110,000 |
| MORRISSEY MICHAEL | President and CEO | 08/09/2018 | 716,523 |
| MORRISSEY MICHAEL | President and CEO | 08/08/2018 | 2,102,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 08/06/2018 | 49,392 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/01/2018 | 123,750 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/01/2018 | 462,600 |
| MORRISSEY MICHAEL | President and CEO | 07/16/2018 | 495,000 |
| MORRISSEY MICHAEL | President and CEO | 07/16/2018 | 1,901,700 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 07/02/2018 | 123,750 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 07/02/2018 | 477,000 |
| MORRISSEY MICHAEL | President and CEO | 06/25/2018 | 495,000 |
| MORRISSEY MICHAEL | President and CEO | 06/25/2018 | 1,765,800 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/31/2018 | 1,346,150 |
| FELDBAUM CARL B | Director | 05/30/2018 | 62,795 |
| FELDBAUM CARL B | Director | 05/30/2018 | 705,797 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 06/01/2018 | 123,750 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 06/01/2018 | 468,000 |
| WILLSEY LANCE | Director | 05/22/2018 | 1,070,000 |
| MORRISSEY MICHAEL | President and CEO | 05/24/2018 | 495,000 |
| MORRISSEY MICHAEL | President and CEO | 05/24/2018 | 1,849,500 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/18/2018 | 79,157 |
| SCANGOS GEORGE A | Director | 05/15/2018 | 174,900 |
| MARCHESI VINCENT T | Director | 05/11/2018 | 174,900 |
| MARCHESI VINCENT T | Director | 05/11/2018 | 285,450 |
| COHEN CHARLES | Director | 05/09/2018 | 174,900 |
| COHEN CHARLES | Director | 05/09/2018 | 321,300 |
| PAPADOPOULOS STELIOS | Director | 05/07/2018 | 174,900 |
| PAPADOPOULOS STELIOS | Director | 05/07/2018 | 332,250 |
| Hessekiel Jeffrey | EVP and General Counsel | 05/04/2018 | 447,200 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/07/2018 | 28,500 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/04/2018 | 19,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/07/2018 | 330,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/04/2018 | 280,847 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 05/03/2018 | 123,750 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 05/03/2018 | 519,417 |
| Hessekiel Jeffrey | EVP and General Counsel | 04/27/2018 | 42,500 |
| Haley Patrick J. | Sr. Vice President, Commercial | 04/24/2018 | 34,000 |
| WYSZOMIERSKI JACK L | Director | 04/16/2018 | 294,450 |
| WYSZOMIERSKI JACK L | Director | 04/16/2018 | 302,920 |
| Garber Alan M | Director | 04/16/2018 | 174,900 |
| Garber Alan M | Director | 04/16/2018 | 303,750 |
| MORRISSEY MICHAEL | President and CEO | 04/11/2018 | 495,000 |
| MORRISSEY MICHAEL | President and CEO | 04/11/2018 | 1,870,200 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 04/06/2018 | 104,763 |
| FELDBAUM CARL B | Director | 03/05/2018 | 128,260 |
| FELDBAUM CARL B | Director | 03/05/2018 | 262,680 |
| COHEN CHARLES | Director | 03/05/2018 | 119,550 |
| COHEN CHARLES | Director | 03/05/2018 | 363,450 |
| MARCHESI VINCENT T | Director | 03/06/2018 | 119,550 |
| MARCHESI VINCENT T | Director | 03/06/2018 | 370,950 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 03/01/2018 | 32,235 |
| PAPADOPOULOS STELIOS | Director | 03/02/2018 | 119,550 |
| PAPADOPOULOS STELIOS | Director | 03/02/2018 | 360,750 |
| WILLSEY LANCE | Director | 03/02/2018 | 294,450 |
| WILLSEY LANCE | Director | 03/02/2018 | 717,300 |
| Haley Patrick J. | Sr. Vice President, Commercial | 02/28/2018 | 35,200 |
| Haley Patrick J. | Sr. Vice President, Commercial | 02/28/2018 | 1,221,637 |
| POSTE GEORGE | Director | 02/28/2018 | 174,900 |
| POSTE GEORGE | Director | 02/28/2018 | 393,900 |
| Garber Alan M | Director | 01/09/2018 | 91,655 |
| Garber Alan M | Director | 01/08/2018 | 27,895 |
| Garber Alan M | Director | 01/08/2018 | 109,515 |
| Garber Alan M | Director | 01/09/2018 | 345,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/15/2017 | 54,549 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 11/15/2017 | 64,573 |
| Haley Patrick J. | Sr. Vice President, Commercial | 11/15/2017 | 92,540 |
| Hessekiel Jeffrey | EVP and General Counsel | 11/15/2017 | 52,470 |
| Senner Christopher J. | EVP and CFO | 11/15/2017 | 68,360 |
| MORRISSEY MICHAEL | President and CEO | 11/15/2017 | 206,588 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/27/2017 | 4,374 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/28/2017 | 47,500 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/28/2017 | 608,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 09/27/2017 | 55,018 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/28/2017 | 330,340 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/27/2017 | 330,330 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/26/2017 | 330,330 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/28/2017 | 791,349 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/27/2017 | 797,992 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 09/26/2017 | 789,325 |
| PAPADOPOULOS STELIOS | Director | 09/22/2017 | 254,000 |
| PAPADOPOULOS STELIOS | Director | 09/19/2017 | 3,530,838 |
| PAPADOPOULOS STELIOS | Director | 09/18/2017 | 2,004,550 |
| Haley Patrick J. | Sr. Vice President, Commercial | 09/14/2017 | 1,650,014 |
| WILLSEY LANCE | Director | 09/13/2017 | 1,348,500 |
| WILLSEY LANCE | Director | 09/12/2017 | 1,339,500 |
| Senner Christopher J. | EVP and CFO | 09/12/2017 | 366,000 |
| Senner Christopher J. | EVP and CFO | 09/12/2017 | 2,679,000 |
| MORRISSEY MICHAEL | President and CEO | 09/12/2017 | 170,000 |
| MORRISSEY MICHAEL | President and CEO | 09/14/2017 | 170,000 |
| MORRISSEY MICHAEL | President and CEO | 09/13/2017 | 170,000 |
| MORRISSEY MICHAEL | President and CEO | 09/14/2017 | 2,708,000 |
| MORRISSEY MICHAEL | President and CEO | 09/13/2017 | 2,704,000 |
| MORRISSEY MICHAEL | President and CEO | 09/12/2017 | 2,659,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 05/30/2017 | 92,300 |
| FELDBAUM CARL B | Director | 05/15/2017 | 166,190 |
| FELDBAUM CARL B | Director | 05/15/2017 | 711,831 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 05/15/2017 | 63,005 |
| MORRISSEY MICHAEL | President and CEO | 05/09/2017 | 190,000 |
| MORRISSEY MICHAEL | President and CEO | 05/08/2017 | 21,470 |
| MORRISSEY MICHAEL | President and CEO | 05/10/2017 | 185,910 |
| MORRISSEY MICHAEL | President and CEO | 05/09/2017 | 2,168,706 |
| MORRISSEY MICHAEL | President and CEO | 05/08/2017 | 246,453 |
| MORRISSEY MICHAEL | President and CEO | 05/10/2017 | 2,207,000 |
| MORRISSEY MICHAEL | President and CEO | 05/04/2017 | 112,383 |
| MORRISSEY MICHAEL | President and CEO | 05/03/2017 | 190,000 |
| MORRISSEY MICHAEL | President and CEO | 05/05/2017 | 190,000 |
| MORRISSEY MICHAEL | President and CEO | 05/04/2017 | 1,311,333 |
| MORRISSEY MICHAEL | President and CEO | 05/03/2017 | 2,266,803 |
| MORRISSEY MICHAEL | President and CEO | 05/05/2017 | 2,184,702 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 05/01/2017 | 891,008 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 05/01/2017 | 2,068,519 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 04/17/2017 | 99,992 |
| MARCHESI VINCENT T | Director | 04/03/2017 | 105,300 |
| MARCHESI VINCENT T | Director | 04/03/2017 | 213,000 |
| WYSZOMIERSKI JACK L | Director | 03/31/2017 | 105,300 |
| WYSZOMIERSKI JACK L | Director | 03/31/2017 | 111,085 |
| COHEN CHARLES | Director | 03/27/2017 | 105,300 |
| Hessekiel Jeffrey | EVP and General Counsel | 03/27/2017 | 144,702 |
| Hessekiel Jeffrey | EVP and General Counsel | 03/22/2017 | 93,500 |
| Hessekiel Jeffrey | EVP and General Counsel | 03/22/2017 | 488,585 |
| FELDBAUM CARL B | Director | 03/20/2017 | 105,300 |
| FELDBAUM CARL B | Director | 03/20/2017 | 217,700 |
| PAPADOPOULOS STELIOS | Director | 03/20/2017 | 105,300 |
| PAPADOPOULOS STELIOS | Director | 03/20/2017 | 216,600 |
| WILLSEY LANCE | Director | 03/15/2017 | 105,300 |
| WILLSEY LANCE | Director | 03/15/2017 | 228,600 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 03/15/2017 | 310,179 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 03/15/2017 | 1,126,658 |
| COHEN CHARLES | Director | 03/13/2017 | 218,200 |
| MARCHESI VINCENT T | Director | 03/10/2017 | 125,200 |
| MARCHESI VINCENT T | Director | 03/10/2017 | 879,200 |
| Hessekiel Jeffrey | EVP and General Counsel | 03/03/2017 | 727,000 |
| Hessekiel Jeffrey | EVP and General Counsel | 03/03/2017 | 2,303,678 |
| MORRISSEY MICHAEL | President and CEO | 03/06/2017 | 991,000 |
| MORRISSEY MICHAEL | President and CEO | 03/03/2017 | 991,000 |
| MORRISSEY MICHAEL | President and CEO | 03/06/2017 | 2,261,000 |
| MORRISSEY MICHAEL | President and CEO | 03/03/2017 | 2,283,000 |
| Haley Patrick J. | Sr. Vice President, Commercial | 03/03/2017 | 57,600 |
| Senner Christopher J. | EVP and CFO | 03/03/2017 | 250,800 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 03/01/2017 | 331,350 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 03/01/2017 | 998,550 |
| POSTE GEORGE | Director | 03/01/2017 | 93,190 |
| POSTE GEORGE | Director | 03/02/2017 | 303,659 |
| POSTE GEORGE | Director | 03/02/2017 | 1,521,892 |
| POSTE GEORGE | Director | 03/01/2017 | 196,293 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/01/2017 | 484,300 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/01/2017 | 1,305,500 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 01/03/2017 | 401,800 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 01/03/2017 | 1,025,636 |
| FELDBAUM CARL B | Director | 12/16/2016 | 260,250 |
| FELDBAUM CARL B | Director | 12/16/2016 | 425,750 |
| Garber Alan M | Director | 12/09/2016 | 105,300 |
| Garber Alan M | Director | 12/09/2016 | 132,361 |
| SCANGOS GEORGE A | Director | 12/07/2016 | 3,200 |
| SCANGOS GEORGE A | Director | 12/05/2016 | 3,218,204 |
| SCANGOS GEORGE A | Director | 12/07/2016 | 3,150 |
| SCANGOS GEORGE A | Director | 12/05/2016 | 3,646,027 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/01/2016 | 368,800 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 12/01/2016 | 1,166,200 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 12/01/2016 | 197,780 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 12/01/2016 | 368,060 |
| Senner Christopher J. | EVP and CFO | 07/15/2016 | 394,578 |
| MORRISSEY MICHAEL | President and CEO | 11/09/2016 | 1,798,000 |
| MORRISSEY MICHAEL | President and CEO | 11/09/2016 | 3,000,000 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 11/09/2016 | 197,780 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 11/09/2016 | 330,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/09/2016 | 362,000 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 11/09/2016 | 920,500 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/31/2016 | 1,290,801 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/31/2016 | 1,440,082 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/04/2016 | 411,949 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 08/04/2016 | 465,718 |
| Hessekiel Jeffrey | EVP and General Counsel | 06/01/2016 | 340,000 |
| WILLSEY LANCE | Director | 05/11/2016 | 99,000 |
| WILLSEY LANCE | Director | 05/09/2016 | 198,900 |
| Schwab Gisela | Pres Prod Dev & Med Aff & CMO | 02/11/2016 | 105,974 |
| Lamb Peter | EVP, Scientific Strategy & CSO | 02/11/2016 | 106,907 |
| Hessekiel Jeffrey | EVP and General Counsel | 02/11/2016 | 82,047 |
| Senner Christopher J. | EVP and CFO | 02/11/2016 | 87,549 |
| MORRISSEY MICHAEL | President and CEO | 02/11/2016 | 181,226 |
| WILLSEY LANCE | Director | 12/11/2015 | 239,000 |
| WILLSEY LANCE | Director | 12/10/2015 | 249,550 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/16/2015 | 290,221 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/16/2015 | 298,984 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/13/2015 | 3,378 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/12/2015 | 1,690,554 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/13/2015 | 3,480 |
| Lamb Peter | EVP, Discovery Research & CSO | 10/12/2015 | 1,753,312 |
| MARCHESI VINCENT T | Director | 09/17/2014 | 34,199 |
| WILLSEY LANCE | Director | 08/29/2013 | 51,454 |
| MARCHESI VINCENT T | Director | 12/20/2012 | 18,720 |
| MARCHESI VINCENT T | Director | 12/19/2012 | 7,005 |
| MARCHESI VINCENT T | Director | 12/18/2012 | 7,230 |
| MARCHESI VINCENT T | Director | 12/17/2012 | 14,093 |
| Schwab Gisela | EVP and Chief Medical Officer | 12/10/2012 | 109,750 |
| MARCHESI VINCENT T | Director | 06/14/2012 | 35,911 |
| RIVERA LUPE M | EVP, Operations | 12/17/2010 | 160,317 |
| RIVERA LUPE M | EVP, Operations | 12/17/2010 | 250,130 |
| RIVERA LUPE M | EVP, Operations | 12/15/2010 | 281,500 |
| RIVERA LUPE M | EVP, Operations | 12/14/2010 | 140,750 |
| RIVERA LUPE M | EVP, Operations | 12/15/2010 | 387,500 |
| RIVERA LUPE M | EVP, Operations | 12/14/2010 | 175,000 |
| Schwab Gisela | EVP & Chief Medical Officer | 12/09/2010 | 26,728 |
| WILLSEY LANCE | Director | 09/07/2010 | 77,171 |
| WILLSEY LANCE | Director | 09/03/2010 | 53,299 |
| WILLSEY LANCE | Director | 08/30/2010 | 226,515 |
| WILLSEY LANCE | Director | 08/27/2010 | 93,539 |
| KARBE FRANK | EVP & CFO | 08/24/2010 | 49,165 |
| PAPADOPOULOS STELIOS | Director | 08/24/2010 | 610,197 |
| WILLSEY LANCE | Director | 08/16/2010 | 155,350 |
| WILLSEY LANCE | Director | 08/13/2010 | 137,690 |
| MORRISSEY MICHAEL | President & CEO | 08/13/2010 | 88,344 |
Load More Insider Transactions
FUNDS WITH A POSITION IN EXELIXIS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 36,014,432 | 0.02% | -2.73% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 26,634,500 | 3.17% | 2.99% | Event Driven, Value |
| RENAISSANCE TECHNOLOGIES LLC | 15,615,716 | 0.58% | 2.62% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 5,145,318 | 0.01% | 1.39% | Other |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,615,300 | 0.32% | 2.1% | Other |
| AQR CAPITAL MANAGEMENT LLC | 2,178,705 | 0.1% | 8.08% | Other |
| D. E. SHAW & CO., INC. | 854,140 | 0.02% | -43.04% | Other |
| CANDRIAM S.C.A. | 711,625 | 0.12% | No change | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 156,395 | 0.07% | 5.45% | Other |
| TUDOR INVESTMENT CORP ET AL | 139,210 | 0.03% | -18.15% | Event Driven, Other |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 25,195 | 0.00144% | No change | Value |
| PZENA INVESTMENT MANAGEMENT LLC | 18,979 | 0.00171% | -13.84% | Value |
| BALYASNY ASSET MANAGEMENT L.P. | 15,726 | 0.00071% | 44.95% | Event Driven |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,400 | 0.00372% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR EXELIXIS INC
STOCK BUYBACKS FOR EXELIXIS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-1.95%
1Q
06/30/2023
-4.36%
2Q
03/31/2023
-4.06%
3Q
12/31/2022
-3.67%
4Q
09/30/2022
-3.70%
5Q
06/30/2022
-3.66%
6Q
03/31/2022
-3.17%
7Q
12/31/2021
-3.14%
8Q
09/30/2021
-2.79%
9Q
06/30/2021
-3.07%
10Q
03/31/2021
-2.57%
11Q
12/31/2020
-2.03%
12Q
09/30/2020
1.26%
13Q
06/30/2020
-1.61%
14Q
03/31/2020
-0.89%
15Q
12/31/2019
-0.59%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR EXELIXIS INC
LOADING...